RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Alcohol-Related Disorders
Accession: DOID:9004354
browse the term
Definition: Disorders related to or resulting from abuse or mis-use of alcohol.
Synonyms: exact_synonym: Alcohol-Related Disorder
primary_id: MESH:D019973
G
BDNF
brain derived neurotrophic factor
sexual_dimorphism
ISO
protein:altered expression:brain protein:altered expression:frontal cortex,hippocampus,occipital cortex protein:altered expression:cerebral cortex
RGD
PMID:10837897 PMID:18652597 PMID:14604765
RGD:401965408 , RGD:401976540 , RGD:401976539
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
CARTPT
CART prepropeptide
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22823101
NCBI chr 5:71,719,275...71,721,045
Ensembl chr 5:71,719,275...71,721,048
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:30118883
RGD:13782287
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CD4
CD4 molecule
sexual_dimorphism
ISO
associated with Mycobacterium Infections;protein:decreased expression:spleen (rat) protein:increases expression:spleen (rat)
RGD
PMID:9744851 PMID:8214423
RGD:407446372 , RGD:407446376
NCBI chr12:6,789,528...6,820,799
Ensembl chr12:6,786,858...6,820,799
G
CRH
corticotropin releasing hormone
sexual_dimorphism
ISO
mRNA:increased expression:fetus, thymus
RGD
PMID:8977428
RGD:405878076
NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
protein:increased expression:liver
RGD
PMID:9731567
RGD:405101375
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
protein:increased expression:liver
RGD
PMID:9731567
RGD:405101375
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
NGF
nerve growth factor
ISO
protein:altered expression:brain protein:decreased expression:entorhinal cortex protein:increased expression:frontal cortex,cerebellar vermis protein:increased expression:cerebral cortex protein:increased expression:thalamus
RGD
PMID:10837897 PMID:10440485 PMID:18652597 PMID:14604765 PMID:21277941
RGD:401965408 , RGD:401976542 , RGD:401976540 , RGD:401976539 , RGD:401976494
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NGFR
nerve growth factor receptor
ISO
protein:decreased expression:brain protein:altered expression:brain
RGD
PMID:15188276 PMID:15188277
RGD:401976554 , RGD:401976555
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
NTF3
neurotrophin 3
ISO
protein:increased expression:hippocampus,cerebellar vermis
RGD
PMID:18652597
RGD:401976540
NCBI chr12:5,430,332...5,495,299
Ensembl chr12:5,432,108...5,521,536
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
protein:altered expression:brain protein:decreased expression:brain
RGD
PMID:15188276 PMID:15188277
RGD:401976554 , RGD:401976555
NCBI chr 1:156,815,750...156,881,850
Ensembl chr 1:156,815,636...156,881,850
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ISO
protein:altered expression:brain
RGD
PMID:15188276 PMID:15188277
RGD:401976554 , RGD:401976555
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
NTRK3
neurotrophic receptor tyrosine kinase 3
ISO
protein:altered expression:brain
RGD
PMID:15188276 PMID:15188277
RGD:401976554 , RGD:401976555
NCBI chr15:87,859,751...88,256,739
Ensembl chr15:87,859,751...88,256,791
G
OPRK1
opioid receptor kappa 1
treatment
ISO
RGD
PMID:20962231
RGD:401850591
NCBI chr 8:53,225,724...53,251,637
Ensembl chr 8:53,225,724...53,251,637
G
POMC
proopiomelanocortin
sexual_dimorphism
ISO
mRNA:decreased expression:fetus, thymus
RGD
PMID:8977428
RGD:405878076
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
ALDH2
aldehyde dehydrogenase 2 family member
IAGP
ClinVar Annotator: match by term: Alcohol sensitivity, acute ClinVar Annotator: match by term: Susceptibility to hangover
ClinVar
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:15902904 PMID:16046871 PMID:16440063 PMID:16679777 PMID:17885622 PMID:18056758 PMID:20010786 PMID:22992668 PMID:25741868 PMID:28492532 PMID:33355142 More...
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ADCYAP1
adenylate cyclase activating polypeptide 1
susceptibility
IAGP
DNA:SNP:: (rs2856966) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr18:904,411...912,172
Ensembl chr18:904,871...912,172
G
ADH1B
alcohol dehydrogenase 1B (class I), beta polypeptide
IAGP
ClinVar Annotator: match by term: Alcohol dependence
ClinVar OMIM
PMID:2398055 PMID:2547609 PMID:3619918 PMID:6354175 PMID:6374651 PMID:7003596 PMID:7035335 PMID:10697413 PMID:12050823 PMID:17718394 More...
NCBI chr 4:99,304,971...99,321,401
Ensembl chr 4:99,304,971...99,321,401
G
ADH1C
alcohol dehydrogenase 1C (class I), gamma polypeptide
susceptibility
IAGP
ClinVar Annotator: match by term: Alcohol dependence associated with other drug dependencies; DNA:SNPs:CDS: (rs904096)
ClinVar OMIM RGD
PMID:3397059 PMID:3758060 PMID:10090900 PMID:15863807 PMID:17718394 PMID:17923853 PMID:27151647 More...
RGD:405650603
NCBI chr 4:99,336,497...99,352,746
Ensembl chr 4:99,336,497...99,352,746
G
ADH4
alcohol dehydrogenase 4 (class II), pi polypeptide
IAGP
RGD
PMID:20077761
RGD:401827938
NCBI chr 4:99,123,658...99,144,297
Ensembl chr 4:99,123,657...99,157,792
G
ADRA2A
adrenoceptor alpha 2A
susceptibility
IAGP ISO
DNA:SNP:promoter: C-1291G (rs1800544) (human) associated with stress-related disorder; mRNA:decreased expression:hypothalamus (rat)
RGD
PMID:21070505 PMID:26121187
RGD:401976462 , RGD:401976544
NCBI chr10:111,077,029...111,080,907
Ensembl chr10:111,077,029...111,080,907
G
AGO1
argonaute RISC component 1
susceptibility
IAGP
DNA:SNP:intron:A>G(rs595961)(human)
RGD
PMID:25495208
RGD:401900681
NCBI chr 1:35,869,761...35,930,532
Ensembl chr 1:35,869,808...35,930,532
G
AGO2
argonaute RISC catalytic component 2
susceptibility
IAGP
DNA:SNP:promoter:A>C(rs4961280)(human)
RGD
PMID:25495208
RGD:401900681
NCBI chr 8:140,520,156...140,642,313
Ensembl chr 8:140,520,156...140,635,633
G
AHR
aryl hydrocarbon receptor
IEP
mRNA:decreased expression:duodenum:
RGD
PMID:34454169
RGD:405866377
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
ALDH2
aldehyde dehydrogenase 2 family member
IAGP
ClinVar Annotator: match by term: Alcohol dependence DNA:SNP: :1510G>A (human)
ClinVar RGD
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:15902904 PMID:16046871 PMID:16440063 PMID:16679777 PMID:17885622 PMID:18056758 PMID:20010786 PMID:22992668 PMID:33355142 PMID:20077761 PMID:16679777 More...
RGD:401827938 , RGD:401827936
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ANGPT1
angiopoietin 1
IAGP
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs10090742)
RGD
PMID:27151647
RGD:405650603
NCBI chr 8:107,249,482...107,497,918
Ensembl chr 8:107,249,482...107,498,055
G
ANKK1
ankyrin repeat and kinase domain containing 1
susceptibility
IAGP
DNA:polymorphism:exon: DNA:SNP,haplotype:exon:rs1800497(human)
RGD
PMID:28574012 PMID:23443985
RGD:401959222 , RGD:401959307
NCBI chr11:113,387,779...113,400,416
Ensembl chr11:113,387,779...113,400,416
G
AR
androgen receptor
severity
IAGP
DNA:repeats:N-terminal
RGD
PMID:19231085
RGD:407424612
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
ARRB2
arrestin beta 2
ISO
mRNA:decreased expression:nucleus accumbens
RGD
PMID:34919270
RGD:401938593
NCBI chr17:4,710,632...4,721,497
Ensembl chr17:4,710,596...4,721,499
G
AVPR1B
arginine vasopressin receptor 1B
ISO
RGD
PMID:21309953
RGD:14700679
NCBI chr 1:206,106,936...206,117,388
Ensembl chr 1:206,106,936...206,117,699
G
BDNF
brain derived neurotrophic factor
treatment
ISO
RGD
PMID:34453945 PMID:32579730
RGD:401959604 , RGD:401959610
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BMAL1
basic helix-loop-helix ARNT like 1
susceptibility
IAGP
DNA:SNP::(rs6486120) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,652...13,387,266
G
BMAL2
basic helix-loop-helix ARNT like 2
susceptibility
IAGP
DNA:SNPs, haplotype:: (rs7958822,rs4964057) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr12:27,332,836...27,425,286
Ensembl chr12:27,332,836...27,425,289
G
BPTF
bromodomain PHD finger transcription factor
IAGP
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs11870068)
RGD
PMID:27151647
RGD:405650603
NCBI chr17:67,825,503...67,984,378
Ensembl chr17:67,825,503...67,984,378
G
CACNA1C
calcium voltage-gated channel subunit alpha1 C
ISO
mRNA, protein:increased expression:amygdala, hippocampus (rat) protein:increased expression:inferior colliculus (human)
RGD
PMID:27905406 PMID:25556199
RGD:152985537 , RGD:152985539
NCBI chr12:1,970,780...2,697,950
Ensembl chr12:1,970,772...2,697,950
G
CCK
cholecystokinin
susceptibility
IAGP
DNA:SNP:promoter: -45C>T (human)
RGD
PMID:9622381
RGD:407419865
NCBI chr 3:42,257,826...42,266,185
Ensembl chr 3:42,257,825...42,266,185
G
CDK20
cyclin dependent kinase 20
susceptibility
IAGP
DNA:SNP:: (rs560019) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr 9:87,966,441...87,974,533
Ensembl chr 9:87,966,441...87,974,753
G
CHAT
choline O-acetyltransferase
ISO
protein:decreased expression:hippocampus,septum,striatum
RGD
PMID:8436061
RGD:401976285
NCBI chr10:49,609,095...49,667,942
Ensembl chr10:49,609,095...49,667,942
G
CHRNA3
cholinergic receptor nicotinic alpha 3 subunit
susceptibility
IAGP
DNA:missense:exons:p.R37H,p.E363D(human)
RGD
PMID:24057674
RGD:405849397
NCBI chr15:78,593,052...78,620,996
Ensembl chr15:78,593,052...78,621,295
G
CHRNB3
cholinergic receptor nicotinic beta 3 subunit
susceptibility
IAGP
DNA:missense:exons:multiple(human)
RGD
PMID:24057674
RGD:405849397
NCBI chr 8:42,697,366...42,737,407
Ensembl chr 8:42,697,366...42,737,407
G
CLOCK
clock circadian regulator
exacerbates
ISO
RGD
PMID:23722243
RGD:401976471
NCBI chr 4:55,427,903...55,546,909
Ensembl chr 4:55,427,903...55,546,909
G
COMT
catechol-O-methyltransferase
susceptibility sexual_dimorphism onset disease_progression
IAGP IDA
associated with Alzheimer's disease; DNA:SNP:cd: P.V158M G>A (rs4680) (human) DNA:SNPs,haplotypes:: (rs165774,rs4680) (human) DNA:SNPs,haplotype:exon 4: p.V158M (rs4680) (human) DNA:SNP:cd: p.V158M (rs4680) (human) DNA:SNP:cd: p.V158M (human) associated with major depressive disorder; DNA:SNP:cd: p.V158M (human) DNA:polymorphism:exon 4: p.V158M (rs4680)(human) associated with schizophrenia; DNA:promoter:Hypermethylation associated with Trauma and Stressor Related Disorders ; DNA:polymorphism:exon: p.V158M (human)
RGD
PMID:25491588 PMID:22208661 PMID:16499480 PMID:24390676 PMID:16648777 PMID:20860878 PMID:25035107 PMID:16984965 PMID:20517217 PMID:11244495 PMID:31150143 PMID:10698363 More...
RGD:11073926 , RGD:401959747 , RGD:401959300 , RGD:401940156 , RGD:401940155 , RGD:401940149 , RGD:401940148 , RGD:401940146 , RGD:401940133 , RGD:401940131 , RGD:401940120 , RGD:401940118
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
G
CPE
carboxypeptidase E
IAGP
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs10517844) DNA:SNP:CDS: (rs13706874) (human)
RGD
PMID:27151647 PMID:20201924
RGD:405650603 , RGD:405650609
NCBI chr 4:165,379,008...165,498,547
Ensembl chr 4:165,361,194...165,498,547
G
CREB1
cAMP responsive element binding protein 1
treatment
IAGP ISO
DNA:SNP:exon:rs35349697 protein:increased phosphorylation:prefrontal cortex (rat) mRNA,protein:decreased expression:hippocampus
RGD
PMID:24704376 PMID:19324071 PMID:21951632 PMID:32579730 PMID:34453945 PMID:37031608 More...
RGD:401938627 , RGD:401901600 , RGD:401959743 , RGD:401959610 , RGD:401959604 , RGD:401959603
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CYP2C9
cytochrome P450 family 2 subfamily C member 9
IEP
protein:increased expression:frontal cortex, microsome
RGD
PMID:25504503
RGD:405100234
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6
IEP
protein:increased expression:brain
RGD
PMID:12354285
RGD:401901262
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO
RGD
PMID:9927612
RGD:405650696
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
ISO
RGD
PMID:9927612
RGD:405650696
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
DGCR8
DGCR8 microprocessor complex subunit
susceptibility
IAGP
DNA:SNP:3���-UTR:G>T(rs1640299)(human)
RGD
PMID:25495208
RGD:401900681
NCBI chr22:20,080,241...20,111,872
Ensembl chr22:20,080,221...20,111,877
G
DRD1
dopamine receptor D1
ISO
RGD
PMID:17360123
RGD:405100958
NCBI chr 5:175,440,036...175,444,182
Ensembl chr 5:175,440,036...175,444,182
G
DRD2
dopamine receptor D2
onset susceptibility
IAGP
DNA:insertion, deletion:promoter: DNA:SNP: :rs1800498(human)
RGD
PMID:23238469 PMID:36825486
RGD:401959213 , RGD:401959301
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
DRD4
dopamine receptor D4
no_association
IAGP
DNA:repeats:exon:
RGD
PMID:9342196
RGD:401959738
NCBI chr11:637,269...640,706
Ensembl chr11:637,269...640,706
G
FKBP5
FKBP prolyl isomerase 5
susceptibility
ISO IAGP
associated with stress-related disorder;DNA:SNP:: (rs1360780) (human) associated with stress-related disorder;mRNA:affects expression:ventral tegmental area,cingulate cortex, nucleus accumbens( rat) DNA:SNPs:intron,3'utr: (rs1360780, rs3800373)
RGD
PMID:27527158 PMID:27709495 PMID:27709495 PMID:27527158
RGD:401976484 , RGD:401976487 , RGD:401976487 , RGD:401976484
NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,573,585...35,728,583
G
FMN1
formin 1
IAGP
associated with other drug dependencies; DNA:SNPs:CDS: (rs3910705)
RGD
PMID:27151647
RGD:405650603
NCBI chr15:32,765,544...33,194,714
Ensembl chr15:32,765,544...33,194,714
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
ISO
protein:increased expression:granular insular cortex, paraventricular nucleus of thalamus, prefrontal cortex
RGD
PMID:29926762 PMID:17723286 PMID:14574439 PMID:17360123
RGD:405100722 , RGD:405295497 , RGD:405101697 , RGD:405100958
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FOSB
FosB proto-oncogene, AP-1 transcription factor subunit
treatment
ISO
protein:increased expression:nucleus accumbens (rat) associated with Sleep Deprivation;protein:increased expression:brain
RGD
PMID:20626732 PMID:19324071 PMID:33662520
RGD:401851075 , RGD:401901600 , RGD:401900733
NCBI chr19:45,467,996...45,475,179
Ensembl chr19:45,467,995...45,475,179
G
GABBR1
gamma-aminobutyric acid type B receptor subunit 1
susceptibility treatment
IAGP ISO HEP
DNA:SNP, haplotype:intron: C>G (rs29220) (human) DNA:SNP:Exon 11: T1974C (Human) mRNA:decreased expression:hippocampus (human) DNA:SNP:intron: (rs29220) (human) DNA:SNP:intron: (rs29253) (human)
RGD
PMID:26727527 PMID:36095322 PMID:36095322 PMID:10412185 PMID:22253714 PMID:29968397 PMID:25191505 More...
RGD:11552767 , RGD:401976442 , RGD:401976442 , RGD:401959601 , RGD:401900163 , RGD:401940102 , RGD:401940100
NCBI chr 6:29,602,238...29,633,183
Ensembl chr 6:29,555,629...29,633,976
G
GABBR2
gamma-aminobutyric acid type B receptor subunit 2
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:22253714
RGD:401900163
NCBI chr 9:98,288,109...98,708,935
Ensembl chr 9:98,288,109...98,708,935
G
GABRA2
gamma-aminobutyric acid type A receptor subunit alpha2
susceptibility
IAGP
ClinVar Annotator: match by term: Alcohol dependence
ClinVar OMIM
PMID:25741868
NCBI chr 4:46,243,548...46,390,300
Ensembl chr 4:46,243,548...46,475,230
G
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
susceptibility
IAGP
DNA:SNPs: :
RGD
PMID:14745296
RGD:405866351
NCBI chr15:26,543,552...26,773,763
Ensembl chr15:26,543,552...26,939,539
G
GABRG2
gamma-aminobutyric acid type A receptor subunit gamma2
IAGP HEP ISO
DNA:SNPs, haplotype:introns:IVS9+99C>A, IVS10+3145A>G (rs211014, rs211013) (human) mRNA:decreased expression:hippocampus (human) mRNA:increased expression:hippocampus (rat)
RGD
PMID:15630072 PMID:22253714 PMID:22253714
RGD:402463959 , RGD:401900163 , RGD:401900163
NCBI chr 5:162,067,465...162,155,539
Ensembl chr 5:162,000,057...162,162,977
G
GAD1
glutamate decarboxylase 1
susceptibility onset
IAGP
DNA:SNPs, haplotype:5'UTR,IVS:Rs3749034,Rs2270335,Rs10439259(human) DNA:SNPs: haplotype:multiple:rs1978340(human)
RGD
PMID:17067345 PMID:19111404
RGD:401900127 , RGD:401900129
NCBI chr 2:170,813,210...170,861,151
Ensembl chr 2:170,813,213...170,861,151
G
GAD2
glutamate decarboxylase 2
susceptibility
IAGP
DNA:SNP::-243A>G (rs2236418)
RGD
PMID:17034009
RGD:401900120
NCBI chr10:26,216,372...26,304,558
Ensembl chr10:26,216,665...26,304,558
G
GDNF
glial cell derived neurotrophic factor
treatment
ISO IEP
protein:decreased expression:serum
RGD
PMID:15659598 PMID:19232578 PMID:20553781 PMID:24801661
RGD:405820207 , RGD:405850246 , RGD:405849399 , RGD:405849388
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
GEMIN4
gem nuclear organelle associated protein 4
susceptibility
IAGP
DNA:SNP:Promoter:C>T(rs910924)(human)
RGD
PMID:25495208
RGD:401900681
NCBI chr17:744,421...754,410
Ensembl chr17:744,421...753,999
G
GGT1
gamma-glutamyltransferase 1
ISO
protein:increased activity:plasma,liver,intestine:
RGD
PMID:6113606
RGD:14701046
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
G
GRIA1
glutamate ionotropic receptor AMPA type subunit 1
ameliorates
ISO
RGD
PMID:33955100
RGD:405649731
NCBI chr 5:153,489,615...153,813,869
Ensembl chr 5:153,489,615...153,813,869
G
GRIN2A
glutamate ionotropic receptor NMDA type subunit 2A
susceptibility ameliorates
IAGP ISO
DNA:repeats:promoter:(GT)n DNA:mutation:cds:A825W(mouse)
RGD
PMID:21507155 PMID:33052417 PMID:29953905
RGD:401938633 , RGD:401938638 , RGD:401938635
NCBI chr16:9,753,404...10,182,908
Ensembl chr16:9,753,404...10,182,928
G
GRM8
glutamate metabotropic receptor 8
susceptibility
IAGP
DNA:SNPs:intron 1: (rs886003, rs17862325) (human)
RGD
PMID:25978827
RGD:11070870
NCBI chr 7:126,438,598...127,252,941
Ensembl chr 7:126,438,598...127,253,093
G
GSTT1
glutathione S-transferase theta 1
IAGP
RGD
PMID:29582627
RGD:14700988
G
HTR1A
5-hydroxytryptamine receptor 1A
IEP IAGP
mRNA:increased expression:Brodmann (1909) area 9 associated with nicotine dependence;DNA:SNPs:enhancer:multiple DNA:SNP: :140G>C
RGD
PMID:22176604 PMID:23216389 PMID:19060480
RGD:401900608 , RGD:405849412 , RGD:401900293
NCBI chr 5:63,957,874...63,962,445
Ensembl chr 5:63,957,874...63,962,507
G
HTR1B
5-hydroxytryptamine receptor 1B
susceptibility onset sexual_dimorphism no_association
IAGP
DNA:SNP:5'UTR:-161A>T (human) DNA:SNP: :861G>C (human) DNA:SNP: :861G>C(human) DNA:SNP,haplotype:promoter:161A>T (human) DNA:SNP:promoter:rs11568817 (human)
RGD
PMID:12022963 PMID:21906503 PMID:11104852 PMID:11827742 PMID:21172311 PMID:22005095 More...
RGD:405650693 , RGD:405847406 , RGD:405847401 , RGD:405818273 , RGD:405650698 , RGD:405650694
NCBI chr 6:77,460,924...77,463,491
Ensembl chr 6:77,460,924...77,463,491
G
HTR2A
5-hydroxytryptamine receptor 2A
disease_progression treatment no_association
IAGP ISO
DNA:SNP: :102T>C (rs6313) protein:decreased expression:agranular insular cortex, cingulate cortex, frontal cortex DNA:SNP:promoter:-1438G>A (rs6311)
RGD
PMID:23321485 PMID:8822536 PMID:15080502 PMID:19328219 PMID:19060480 PMID:21930285 More...
RGD:401900291 , RGD:401900739 , RGD:401900737 , RGD:401900304 , RGD:401900293 , RGD:401900297
NCBI chr13:46,831,546...46,898,082
Ensembl chr13:46,831,546...46,897,076
G
HTR3A
5-hydroxytryptamine receptor 3A
exacerbates treatment susceptibility
IEP HDA IAGP ISO
mRNA:increased expression:peripheral blood mononuclear cell (human) DNA:hypermethylation:promoter DNA:SNPs:enhancer, exon: (rs1150226, rs1176713) (human) DNA:SNPs, haplotype:multiple (human) mRNA:increased expression:prefrontal cortex (rat) DNA:SNP:exon 1: (rs33940208) (human)
RGD
PMID:27144979 PMID:22924764 PMID:23897038 PMID:24590108 PMID:25722691 PMID:23757001 More...
RGD:404976874 , RGD:405096436 , RGD:405096433 , RGD:404976878 , RGD:404976876 , RGD:404976875
NCBI chr11:113,975,108...113,990,313
Ensembl chr11:113,975,075...113,990,313
G
IL1RN
interleukin 1 receptor antagonist
IEP
protein:increased expression:blood
RGD
PMID:14634483
RGD:405878079
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
KCNB2
potassium voltage-gated channel subfamily B member 2
IAGP
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs2251898)
RGD
PMID:27151647
RGD:405650603
NCBI chr 8:72,537,225...72,938,349
Ensembl chr 8:72,537,225...72,938,349
G
LEP
leptin
severity
IDA IEP
DNA:hypermethylation:promoter protein:decreased expression:serum
RGD
PMID:29912265 PMID:19884906 PMID:29912265
RGD:21201248 , RGD:407424613 , RGD:21201248
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
LOC126807122
P300/CBP strongly-dependent group 1 enhancer GRCh37_chr4:100238861-100240060
IAGP
ClinVar Annotator: match by term: Alcohol dependence
ClinVar
PMID:2398055 PMID:2547609 PMID:6374651 PMID:10697413 PMID:12050823
NCBI chr 4:99,317,704...99,318,903
G
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
RGD
PMID:34453945
RGD:401959604
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
RGD
PMID:34453945
RGD:401959604
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
NCAM1
neural cell adhesion molecule 1
susceptibility
IAGP
DNA:SNPs:exon:
RGD
PMID:17761687
RGD:405866369
NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
G
NGF
nerve growth factor
IEP ISO
protein:increased expression:serum protein:decreased expression:sciatic nerve protein:decreased expression:plasma
RGD
PMID:17434673 PMID:8733743 PMID:16737466
RGD:401965399 , RGD:401976493 , RGD:401965409
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NGFR
nerve growth factor receptor
ISO
protein:altered expression:brain,neuron
RGD
PMID:7609866
RGD:401976553
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
NPY
neuropeptide Y
susceptibility
IAGP
DNA:SNP:cd: p.L7P (rs16139) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
G
NR3C2
nuclear receptor subfamily 3 group C member 2
ISO
mRNA:altered expression:central amygdaloid nucleus (rat)
RGD
PMID:28461696
RGD:401960064
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
G
NRM
nurim
IAGP
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs2269705)
RGD
PMID:27151647
RGD:405650603
NCBI chr 6:30,688,049...30,691,420
Ensembl chr 6:30,688,047...30,691,420
G
NRXN3
neurexin 3
susceptibility
IAGP
DNA:SNP,haplotype:Chr14:rs8019381, rs760288|rs8019381|2rs2293847 (human)
RGD
PMID:17804423
RGD:405096431
NCBI chr14:78,170,373...79,868,291
Ensembl chr14:78,170,373...79,868,291
G
NUCB2
nucleobindin 2
ISO
mRNA,protein:decreased expression:hippocampus
RGD
PMID:37031608
RGD:401959603
NCBI chr11:17,276,739...17,349,980
Ensembl chr11:17,208,153...17,349,980
G
OPRD1
opioid receptor delta 1
IAGP
DNA:SNP,haplotype:intron 1 (rs2298896|rs421300), multiple GCAAT (human)
RGD
PMID:17622222
RGD:401976552
NCBI chr 1:28,812,170...28,871,267
Ensembl chr 1:28,812,170...28,871,267
G
OPRK1
opioid receptor kappa 1
no_association
IAGP IEP
DNA:SNPs:intron:multiple DNA:SNP,haplotype:multiple (multiple GGCTTCT) (human) mRNA:increased expression:orbitofrontal cortex DNA:SNP: :rs6473797 (human)
RGD
PMID:16924269 PMID:17622222 PMID:21955155 PMID:24035285
RGD:401850571 , RGD:401976552 , RGD:401850584 , RGD:401850579
NCBI chr 8:53,225,724...53,251,637
Ensembl chr 8:53,225,724...53,251,637
G
OPRM1
opioid receptor mu 1
no_association treatment sexual_dimorphism
IAGP IMP
DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human) DNA:SNP: :rs1799971 (human)
RGD
PMID:16679777 PMID:24035285 PMID:30748046 PMID:11424981 PMID:35992511 PMID:17374034 PMID:18250251 PMID:20077761 PMID:20077761 More...
RGD:401827936 , RGD:401850579 , RGD:401831038 , RGD:401827953 , RGD:401827952 , RGD:401827944 , RGD:11097488 , RGD:401827938 , RGD:401827938
NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
G
PDE4B
phosphodiesterase 4B
susceptibility
IAGP
DNA:SNP:: (rs1937443) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579
G
PDYN
prodynorphin
no_association disease_progression
IAGP IEP
DNA:SNP, hypermethylation:promoter:rs2235751 (human) mRNA, protein:increased expression:dorsolateral prefrontal cortex, orbitofrontal cortex DNA:SNP: :rs1997794 (human) DNA:SNP, hypermethylation:dorsolateral prefrontal cortex:rs2281285 (human) DNA:SNP: :rs2281285 (human) DNA:SNPs: :multiple DNA:SNPs, haplotypes:multiple
RGD
PMID:28336495 PMID:21955155 PMID:24035285 PMID:21521424 PMID:26502829 PMID:16924269 PMID:24223163 PMID:23101464 More...
RGD:401850551 , RGD:401850584 , RGD:401850579 , RGD:401850575 , RGD:11535796 , RGD:401850571 , RGD:401850565 , RGD:401850560
NCBI chr20:1,978,756...1,994,285
Ensembl chr20:1,978,757...1,994,285
G
PER2
period circadian regulator 2
IEP IDA
DNA, mRNA:hypermethylation, decreased expression:blood DNA:hypermethylation:blood, promoter
RGD
PMID:30597578 PMID:31329297
RGD:405878075 , RGD:405878078
NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102
G
PKNOX2
PBX/knotted 1 homeobox 2
IAGP
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs750338)
RGD
PMID:27151647
RGD:405650603
NCBI chr11:125,164,751...125,433,389
Ensembl chr11:125,164,687...125,433,389
G
POMC
proopiomelanocortin
no_association
IAGP IDA ISO IEP
DNA:SNP: :rs934778 (human) DNA:hypermethylation:promoter:blood mRNA:decreased expression:hypothalamus mRNA:increased expression:pituitary gland mRNA:increased expression:blood, lymphocyte DNA:hypermethylation:blood, promoter DNA, mRNA:hypermethylation, decreased expression:blood mRNA:increased expression:blood, lymphocytes
RGD
PMID:24035285 PMID:20191296 PMID:11981131 PMID:7662043 PMID:14634483 PMID:31329297 PMID:30597578 PMID:9426836 More...
RGD:401850579 , RGD:407431644 , RGD:407424597 , RGD:406179436 , RGD:405878079 , RGD:405878078 , RGD:405878075 , RGD:405878074
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
PRL
prolactin
treatment
IEP
RGD
PMID:11418230
RGD:401959332
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
G
RGS6
regulator of G protein signaling 6
IAGP
associated with other drug dependencies; DNA:SNPs:CDS: (rs11621871)
RGD
PMID:27151647
RGD:405650603
NCBI chr14:71,867,335...72,630,029
Ensembl chr14:71,932,429...72,566,530
G
SLC29A1
solute carrier family 29 member 1 (Augustine blood group)
ISS
OMIM:103780
MouseDO
NCBI chr 6:44,219,615...44,234,142
Ensembl chr 6:44,219,553...44,234,142
G
SLC6A1
solute carrier family 6 member 1
susceptibility
IAGP
DNA:insertion:promoter:: (human)
RGD
PMID:26727527
RGD:11552767
NCBI chr 3:10,992,748...11,039,247
Ensembl chr 3:10,992,186...11,039,247
G
SLC6A2
solute carrier family 6 member 2
susceptibility
IAGP
DNA:SNPs,haplotypes:intron: (rs36020,rs36029) (human)
RGD
PMID:21070505
RGD:401976462
NCBI chr16:55,655,988...55,706,192
Ensembl chr16:55,655,988...55,707,645
G
SLC6A4
solute carrier family 6 member 4
disease_progression
IAGP
DNA:VNTR
RGD
PMID:18552399
RGD:401900298
NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
G
TAS2R16
taste 2 receptor member 16
IAGP
OMIM
NCBI chr 7:122,994,704...122,995,700
Ensembl chr 7:122,994,704...122,995,700
G
TBX19
T-box transcription factor 19
susceptibility
IAGP
DNA:SNP:: (rs1003502) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr 1:168,280,877...168,314,426
Ensembl chr 1:168,280,877...168,314,426
G
TTC12
tetratricopeptide repeat domain 12
susceptibility
IAGP
DNA:SNPs:introns,exon:
RGD
PMID:17761687
RGD:405866369
NCBI chr11:113,314,583...113,373,297
Ensembl chr11:113,314,579...113,383,544
G
ATP2A1
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
ISO
RGD
PMID:14506614
RGD:1581765
NCBI chr16:28,878,488...28,904,466
Ensembl chr16:28,878,405...28,904,466
G
ACADS
acyl-CoA dehydrogenase short chain
susceptibility
IAGP
DNA:SNP:: (rs1799958) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr12:120,725,826...120,740,008
Ensembl chr12:120,725,774...120,740,008
G
ADH1B
alcohol dehydrogenase 1B (class I), beta polypeptide
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16404797 PMID:17590986 PMID:21168396
NCBI chr 4:99,304,971...99,321,401
Ensembl chr 4:99,304,971...99,321,401
G
ADH1C
alcohol dehydrogenase 1C (class I), gamma polypeptide
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16404797
NCBI chr 4:99,336,497...99,352,746
Ensembl chr 4:99,336,497...99,352,746
G
ADH5
alcohol dehydrogenase 5 (class III), chi polypeptide
ISO
RGD
PMID:8462548
RGD:5129091
NCBI chr 4:99,070,978...99,088,788
Ensembl chr 4:99,070,978...99,088,801
G
ALDH2
aldehyde dehydrogenase 2 family member
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16404797 PMID:17590986 PMID:10780266
RGD:734551
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ANKK1
ankyrin repeat and kinase domain containing 1
severity
IGI IAGP
DNA:polymorphism: :rs1800497(human) DNA:SNP,haplotype: :rs11604671, rs4938015 (human)
RGD
PMID:32889058 PMID:21936764
RGD:401940151 , RGD:401959296
NCBI chr11:113,387,779...113,400,416
Ensembl chr11:113,387,779...113,400,416
G
ARC
activity regulated cytoskeleton associated protein
ISO
associated with Prenatal Exposure Delayed Effects and anxiety disorder:DNA:Hypermthylation:promoter
RGD
PMID:30016666
RGD:401959614
NCBI chr 8:142,611,049...142,614,479
Ensembl chr 8:142,611,049...142,614,479
G
BDNF
brain derived neurotrophic factor
ISO IEP
protein:decreased expression:plasma protein:decreased expression:cerebellum, hippocampus protein:altered expression:brain mRNA:decreased expression:hippocampus mRNA,protein:decreased expression:hippocampus, plasma (rat) protein:decreased expression:plasma (human)
RGD
PMID:32135570 PMID:19100286 PMID:15307153 PMID:32497709 PMID:30277635 PMID:30277635 More...
RGD:35673317 , RGD:401976492 , RGD:401965482 , RGD:401950485 , RGD:401938665 , RGD:401938665
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
CALB1
calbindin 1
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 8:90,058,608...90,082,879
Ensembl chr 8:90,058,608...90,095,475
G
CAMK2N1
calcium/calmodulin dependent protein kinase II inhibitor 1
ISO
mRNA:increased expression:prefrontal cortex
RGD
PMID:28714806
RGD:18337277
NCBI chr 1:20,482,391...20,486,210
Ensembl chr 1:20,482,391...20,486,210
G
CAMK4
calcium/calmodulin dependent protein kinase IV
ISO
protein:decreased expression:brain, cingulate gyrus
RGD
PMID:11181917
RGD:401959326
NCBI chr 5:111,223,583...111,494,886
Ensembl chr 5:111,223,653...111,494,886
G
CAST
calpastatin
ISO
protein:increased expression:gastrocnemius (rat)
RGD
PMID:28800153
RGD:405100967
NCBI chr 5:95,961,429...96,774,683
Ensembl chr 5:96,525,267...96,779,595 Ensembl chr 5:96,525,267...96,779,595
G
CAT
catalase
treatment
ISO
associated with diabetes; protein:decreased activity;testis, epididymis (rat) associated with cardiomyopathy associated with cognitive disorder; protein:altered activity:hippocampus (rat) associated with diabetes;protein:decreased activity:liver, kidney (rat)
RGD
PMID:22596042 PMID:25541261 PMID:7195942 PMID:27367870 PMID:21713042
RGD:405255659 , RGD:405255664 , RGD:405255663 , RGD:405255662 , RGD:405255660
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCKAR
cholecystokinin A receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:9922984
NCBI chr 4:26,481,396...26,490,484
Ensembl chr 4:26,481,396...26,490,484
G
CDK20
cyclin dependent kinase 20
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 9:87,966,441...87,974,533
Ensembl chr 9:87,966,441...87,974,753
G
CHRNA3
cholinergic receptor nicotinic alpha 3 subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414406
NCBI chr15:78,593,052...78,620,996
Ensembl chr15:78,593,052...78,621,295
G
CHRNA5
cholinergic receptor nicotinic alpha 5 subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414406
NCBI chr15:78,565,520...78,595,269
Ensembl chr15:78,565,520...78,595,269
G
CHRNA6
cholinergic receptor nicotinic alpha 6 subunit
severity
IAGP
DNA:haplotypes: :
RGD
PMID:19698703
RGD:405849410
NCBI chr 8:42,752,620...42,768,786
Ensembl chr 8:42,752,620...42,796,392
G
CLOCK
clock circadian regulator
susceptibility
IAGP
DNA:SNP:: (rs2412648) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 4:55,427,903...55,546,909
Ensembl chr 4:55,427,903...55,546,909
G
CNR1
cannabinoid receptor 1
sexual_dimorphism
ISO
associated with chronic stress in female rats
RGD
PMID:27894930
RGD:401959751
NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
G
COMT
catechol-O-methyltransferase
disease_progression
EXP IGI IAGP
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :rs4680(human) DNA:polymorphism::
CTD RGD
PMID:10395222 PMID:32889058 PMID:10395222
RGD:401940151 , RGD:401940114
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
G
CREB1
cAMP responsive element binding protein 1
sexual_dimorphism
ISO
mRNA, protein:decreased expression:amygdala protein:increased phosphorylation:liver protein:altered expression, altered phosphorylation:liver, nucleus
RGD
PMID:29991681 PMID:31262967 PMID:22269225
RGD:401938626 , RGD:401959334 , RGD:401959317
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CREBBP
CREB binding protein
ISO
mRNA, protein:decreased expression:amygdala
RGD
PMID:29991681
RGD:401938626
NCBI chr16:3,725,054...3,880,713
Ensembl chr16:3,725,054...3,880,713
G
CRH
corticotropin releasing hormone
ISO
mRNA:increased expression:central amygdaloid nucleus (rat)
RGD
PMID:20060104
RGD:5508173
NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
G
CRHR1
corticotropin releasing hormone receptor 1
ISO
RGD
PMID:11988580
RGD:734822
NCBI chr17:45,784,320...45,835,828
Ensembl chr17:45,784,277...45,835,828
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
EXP ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma, extracellular exosome
CTD RGD
PMID:20843640 PMID:23819932 PMID:29404485 PMID:29404485
RGD:14700915 , RGD:14700911 , RGD:14700911
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
DBH
dopamine beta-hydroxylase
no_association
IAGP
DNA:polymorphism:cds:g.444G>A (human) DNA:polymorphism:5' utr:g.-1021C>T (human)
RGD
PMID:16252068 PMID:16133787
RGD:1625571 , RGD:1625572
NCBI chr 9:133,636,363...133,659,329
Ensembl chr 9:133,636,363...133,659,329
G
DCX
doublecortin
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr X:111,293,779...111,412,192
Ensembl chr X:111,293,779...111,412,429
G
DLG4
discs large MAGUK scaffold protein 4
ISO
associated with Prenatal Exposure Delayed Effects and anxiety disorder:mRNA,protein:decreased expression:brain (mouse)
RGD
PMID:30016666
RGD:401959614
NCBI chr17:7,187,187...7,220,050
Ensembl chr17:7,187,187...7,219,836
G
DRD2
dopamine receptor D2
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
DRD4
dopamine receptor D4
treatment susceptibility
IAGP
DNA:repeats:exon: associated with peer pressure;DNA:repeats:exon:
RGD
PMID:25640830 PMID:26307243
RGD:11064848 , RGD:401959598
NCBI chr11:637,269...640,706
Ensembl chr11:637,269...640,706
G
EP300
E1A binding protein p300
ISO
mRNA, protein:decreased expression:amygdala
RGD
PMID:29991681
RGD:401938626
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,510...41,180,077
G
ERCC1
ERCC excision repair 1, endonuclease non-catalytic subunit
ISO
RGD
PMID:23095216
RGD:10045658
NCBI chr19:45,407,334...45,451,547
Ensembl chr19:45,407,334...45,478,828
G
FGF2
fibroblast growth factor 2
ISO
RGD
PMID:28821667 PMID:31375540
RGD:405855870 , RGD:405855874
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
G
FMR1
fragile X messenger ribonucleoprotein 1
ISO
mRNA:increased expression:cerebellum
RGD
PMID:34453331
RGD:401938639
NCBI chr X:147,911,919...147,951,125
Ensembl chr X:147,911,919...147,951,125
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
ISO
protein:increased expression:brain protein:increased expression:parvocellular oculomotor nucleus
RGD
PMID:14741756 PMID:29210146 PMID:11164784
RGD:405255650 , RGD:405295495 , RGD:405255652
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FOSB
FosB proto-oncogene, AP-1 transcription factor subunit
treatment
ISO
protein:increased expression:dorsal striatum (mouse) protein:increased expression:brain (mouse)
RGD
PMID:22792289 PMID:27380261 PMID:9835277
RGD:401851082 , RGD:401901287 , RGD:401901184
NCBI chr19:45,467,996...45,475,179
Ensembl chr19:45,467,995...45,475,179
G
FSHB
follicle stimulating hormone subunit beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
G
GABBR1
gamma-aminobutyric acid type B receptor subunit 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr 6:29,602,238...29,633,183
Ensembl chr 6:29,555,629...29,633,976
G
GABBR2
gamma-aminobutyric acid type B receptor subunit 2
susceptibility
IAGP
DNA:SNP:intron: (rs2900512) (human)
RGD
PMID:28118741
RGD:401940105
NCBI chr 9:98,288,109...98,708,935
Ensembl chr 9:98,288,109...98,708,935
G
GABRA2
gamma-aminobutyric acid type A receptor subunit alpha2
susceptibility
IAGP EXP
DNA:SNPs:multiple: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22253714 PMID:15024690
RGD:6480257
NCBI chr 4:46,243,548...46,390,300
Ensembl chr 4:46,243,548...46,475,230
G
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
susceptibility
IAGP
DNA:CA repeats: :(human)
RGD
PMID:9858031
RGD:405866342
NCBI chr15:26,543,552...26,773,763
Ensembl chr15:26,543,552...26,939,539
G
GABRG2
gamma-aminobutyric acid type A receptor subunit gamma2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr 5:162,067,465...162,155,539
Ensembl chr 5:162,000,057...162,162,977
G
GATA4
GATA binding protein 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20585342
NCBI chr 8:11,676,935...11,760,002
Ensembl chr 8:11,676,959...11,760,002
G
GDNF
glial cell derived neurotrophic factor
treatment
IEP ISO
protein:increased expression:serum associated with Tobacco Use Disorder;mRNA:decreased expression:ventral tegmental area DNA:hypomethylation:nucleus accumbens
RGD
PMID:25623403 PMID:28559549 PMID:22238721 PMID:31710958
RGD:401965480 , RGD:405850249 , RGD:405849387 , RGD:405820205
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
GGT1
gamma-glutamyltransferase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12747453
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
G
GHSR
growth hormone secretagogue receptor
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:23977009
NCBI chr 3:172,443,291...172,448,456
Ensembl chr 3:172,443,291...172,448,456
G
GPHN
gephyrin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr14:66,508,147...67,735,355
Ensembl chr14:66,507,407...67,181,803
G
GRIA1
glutamate ionotropic receptor AMPA type subunit 1
ISO
protein:increased phosphorylation:lumbar spinal cord (mouse) protein:decreased expression:neocortex (rat) protein:increased expression, increased phosphorylation:cingulate cortex (rat) protein:increased expression:nucleus accumbens (mouse) protein:increased expression:nucleus accumbens (rat)
RGD
PMID:28585190 PMID:12036520 PMID:34280506 PMID:21041654 PMID:21041654
RGD:405100727 , RGD:405820203 , RGD:405818275 , RGD:405650686 , RGD:405650686
NCBI chr 5:153,489,615...153,813,869
Ensembl chr 5:153,489,615...153,813,869
G
GRIN1
glutamate ionotropic receptor NMDA type subunit 1
IAGP
RGD
PMID:14573320
RGD:1642372
NCBI chr 9:137,139,154...137,168,756
Ensembl chr 9:137,138,346...137,168,756
G
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
IAGP
RGD
PMID:14573320 PMID:16911840
RGD:1642372 , RGD:1642200
NCBI chr12:13,537,337...13,982,134
Ensembl chr12:13,437,942...13,982,002
G
HDAC2
histone deacetylase 2
ISO
RGD
PMID:23485013
RGD:9590265
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
G
HTR1A
5-hydroxytryptamine receptor 1A
treatment
ISO
RGD
PMID:9631953
RGD:401900760
NCBI chr 5:63,957,874...63,962,445
Ensembl chr 5:63,957,874...63,962,507
G
HTR1B
5-hydroxytryptamine receptor 1B
sexual_dimorphism onset no_association
IAGP
associated with attention deficit hyperactivity disorder;DNA:SNP: :rs11568817(human) DNA:SNP: :rs13212041 (human) DNA:SNPs: :multiples (human)
RGD
PMID:28923721 PMID:30774345 PMID:11496363
RGD:405650695 , RGD:405847403 , RGD:405818272
NCBI chr 6:77,460,924...77,463,491
Ensembl chr 6:77,460,924...77,463,491
G
HTR2A
5-hydroxytryptamine receptor 2A
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:dorsal raphe, nucleus accumbens mRNA, protein:decreased expression:cerebral cortex, liver
CTD RGD
PMID:9631953 PMID:9347073 PMID:9347075 PMID:20501057
RGD:401900760 , RGD:401900742 , RGD:401900740 , RGD:401900301
NCBI chr13:46,831,546...46,898,082
Ensembl chr13:46,831,546...46,897,076
G
HTR2C
5-hydroxytryptamine receptor 2C
treatment
ISO
RGD
PMID:24041931
RGD:401900761
NCBI chr X:114,584,086...114,910,061
Ensembl chr X:114,584,078...114,910,061
G
HTR3A
5-hydroxytryptamine receptor 3A
ISO
DNA:hypermethylation, hypomethylation:promoter: (mouse)
RGD
PMID:22834954
RGD:404976877
NCBI chr11:113,975,108...113,990,313
Ensembl chr11:113,975,075...113,990,313
G
HTR3B
5-hydroxytryptamine receptor 3B
susceptibility
IAGP
DNA:SNP:cds:rs1176744(human)
RGD
PMID:20838391
RGD:6480660
NCBI chr11:113,898,923...113,949,079
Ensembl chr11:113,904,796...113,949,079
G
HTR7
5-hydroxytryptamine receptor 7
IAGP
DNA:SNP:intron: (rs7916403) (human)
RGD
PMID:21184583
RGD:150429835
NCBI chr10:90,740,823...90,858,039
Ensembl chr10:90,740,823...90,858,039
G
IGF2
insulin like growth factor 2
IEP
protein:decreased expression:plasma (human)
RGD
PMID:30277635
RGD:401938665
NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
G
IL10
interleukin 10
ISO
mRNA:increased expression:liver
RGD
PMID:22269225
RGD:401959317
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
KCNJ6
potassium inwardly rectifying channel subfamily J member 6
IAGP
DNA:SNP:promoter:rs2836016 (human)
RGD
PMID:21307845
RGD:6483053
NCBI chr21:37,607,373...37,916,457
Ensembl chr21:37,607,373...38,121,345
G
LHB
luteinizing hormone subunit beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
G
MAOA
monoamine oxidase A
susceptibility
IAGP
RGD
PMID:15900229
RGD:1600720
NCBI chr X:43,655,006...43,746,817
Ensembl chr X:43,654,907...43,746,817
G
MAPK1
mitogen-activated protein kinase 1
ISO
protein:increased expression:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK14
mitogen-activated protein kinase 14
ISO
protein:increased expression, increased phosphorylation:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
G
MAPK3
mitogen-activated protein kinase 3
ISO
protein:increased expression:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPK8
mitogen-activated protein kinase 8
ISO
RGD
PMID:31262967
RGD:401959334
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MCM5
minichromosome maintenance complex component 5
ISO
RGD
PMID:23095216
RGD:10045658
NCBI chr22:35,400,140...35,455,031
Ensembl chr22:35,400,134...35,425,431
G
MIR191
microRNA 191
onset
ISO
RGD
PMID:32135570
RGD:35673317
NCBI chr 3:49,020,618...49,020,709
Ensembl chr 3:49,020,618...49,020,709
G
MIR195
microRNA 195
onset
ISO
RGD
PMID:32135570
RGD:35673317
NCBI chr17:7,017,615...7,017,701
Ensembl chr17:7,017,615...7,017,701
G
MIR206
microRNA 206
onset
ISO
RGD
PMID:32135570
RGD:35673317
NCBI chr 6:52,144,349...52,144,434
Ensembl chr 6:52,144,349...52,144,434
G
MIR30A
microRNA 30a
onset
ISO
RGD
PMID:32135570
RGD:35673317
NCBI chr 6:71,403,551...71,403,621
Ensembl chr 6:71,403,551...71,403,621
G
MKI67
marker of proliferation Ki-67
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
G
MMP2
matrix metallopeptidase 2
ISO
RGD
PMID:24966898
RGD:13207311
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:24966898
RGD:13207311
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
NCAM1
neural cell adhesion molecule 1
sexual_dimorphism treatment
ISO
mRNA:decreased expression:hippocampus (rat) associated with chronic stress in female rats
RGD
PMID:30277635 PMID:27894930 PMID:16207289
RGD:401938665 , RGD:401959751 , RGD:401959613
NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
G
NGF
nerve growth factor
IEP ISO
protein:increased expression:serum protein:decreased expression:cerebral cortex, hippocampus protein:decreased expression:brain
RGD
PMID:25623403 PMID:19100286 PMID:15307153
RGD:401965480 , RGD:401976492 , RGD:401965482
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NPY
neuropeptide Y
ISO EXP IAGP
DNA:deletion:intron:g.4666_4674del (rat) CTD Direct Evidence: marker/mechanism DNA:missense mutation: :p.L7P (human)
CTD RGD
PMID:17572454 PMID:15749341 PMID:12215082
RGD:1357412 , RGD:10430830
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
G
NPY2R
neuropeptide Y receptor Y2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18828811
NCBI chr 4:155,173,723...155,217,076
Ensembl chr 4:155,208,636...155,217,078
G
NR3C2
nuclear receptor subfamily 3 group C member 2
treatment sexual_dimorphism
ISO
RGD
PMID:29437012 PMID:30171933 PMID:33007359
RGD:401965466 , RGD:401976281 , RGD:401966865
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
G
NRG1
neuregulin 1
sexual_dimorphism
IAGP
in female, associated with stressful life event;DNA:SNP: :rs6994992(human)
RGD
PMID:27353026
RGD:405100235
NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666
G
NTF3
neurotrophin 3
IEP ISO
protein:decreased expression:plasma (human) protein:increased expression:brain mRNA,protein:decreased expression:hippocampus, plasma (rat)
RGD
PMID:30277635 PMID:15307153 PMID:30277635
RGD:401938665 , RGD:401965482 , RGD:401938665
NCBI chr12:5,430,332...5,495,299
Ensembl chr12:5,432,108...5,521,536
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ISO
associated with Prenatal Exposure Delayed Effects and anxiety disorder:protein:decreased acetylation:brain
RGD
PMID:30016666 PMID:8840027
RGD:401959614 , RGD:401965407
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
OPRD1
opioid receptor delta 1
ISO IAGP
associated with stress-related disorder; mRNA:decreased expression:dorsal striatum (rat) DNA:SNPs, haplotype:intron 1:multiple (human)
RGD
PMID:28511993 PMID:24533225 PMID:7501658
RGD:401976432 , RGD:402525443 , RGD:401976439
NCBI chr 1:28,812,170...28,871,267
Ensembl chr 1:28,812,170...28,871,267
G
OPRK1
opioid receptor kappa 1
severity susceptibility no_association
IAGP ISO
DNA:SNP, haplotype: :rs6473797 (human) associated with stress-related disorder; mRNA:decreased expression:dorsal striatum (rat) DNA:SNP: :rs6473797 (human) DNA:SNP: :rs997917 (human)
RGD
PMID:31004399 PMID:28511993 PMID:37177778 PMID:37177778
RGD:401831037 , RGD:401976432 , RGD:401850581 , RGD:401850581
NCBI chr 8:53,225,724...53,251,637
Ensembl chr 8:53,225,724...53,251,637
G
OPRL1
opioid related nociceptin receptor 1
ISO
RGD
PMID:11814626
RGD:9835016
NCBI chr20:64,080,082...64,100,643
Ensembl chr20:64,080,082...64,100,643
G
OPRM1
opioid receptor mu 1
treatment no_association
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human) DNA:missense mutations, SNP:exon, intron:p.A6V, p.S147C, p.N40D (118A>G) (rs 1799971), IVS2+691G>C (human) DNA:SNP: :rs510769
CTD RGD
PMID:12815747 PMID:32772383 PMID:9399694 PMID:26042510
RGD:401827947 , RGD:401827934 , RGD:401827930
NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
G
PDE4B
phosphodiesterase 4B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579
G
PDYN
prodynorphin
no_association susceptibility
EXP ISO IAGP
CTD Direct Evidence: marker/mechanism mRNA, protein:decreased expression:hippocampus, granule cell DNA:SNPs: :rs2281285, rs2225749, rs910080 (human) DNA:SNP: :rs2281285 (human) DNA, mRNA:SNP, decreased expression:promoter, dorsolateral prefrontal cortex:rs1997794 (human) associated with cocaine dependence;DNA, mRNA:SNPs, haplotype:3' utr:rs910080, rs910079, rs2235749 (human)
CTD RGD
PMID:17559549 PMID:18923396 PMID:1589146 PMID:37177778 PMID:36099111 PMID:29925858 PMID:18923396 More...
RGD:401851059 , RGD:401850581 , RGD:401850566 , RGD:401850559 , RGD:401850550
NCBI chr20:1,978,756...1,994,285
Ensembl chr20:1,978,757...1,994,285
G
PENK
proenkephalin
ISO
mRNA:increased expression:frontal lobe:
RGD
PMID:22703995
RGD:10003152
NCBI chr 8:56,440,957...56,446,641
Ensembl chr 8:56,436,674...56,446,671
G
POMC
proopiomelanocortin
ISO
protein:decreased expression:brain (rat) mRNA:increased expression: hypothalamus, pituitary gland, shell of nucleus accumbens
RGD
PMID:18162070 PMID:22724395
RGD:401976284 , RGD:405878072
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
RPL18A
ribosomal protein L18a
ISO
mRNA:decreased expression:parietal cortex
RGD
PMID:11244494
RGD:11038708
NCBI chr19:17,859,910...17,863,319
Ensembl chr19:17,859,910...17,864,153
G
SHBG
sex hormone binding globulin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr17:7,614,064...7,633,372
Ensembl chr17:7,613,946...7,633,382
G
SLC6A3
solute carrier family 6 member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
G
SLC6A4
solute carrier family 6 member 4
susceptibility
IDA EXP
protein:decreased activity: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15520362 PMID:17000009 PMID:20838391
RGD:6480660
NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
G
SNCA
synuclein alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18055133
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
G
SOD1
superoxide dismutase 1
ISO
associated with diabetes; protein:decreased activity;testis, epididymis (rat)
RGD
PMID:25541261
RGD:405255664
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOX2
SRY-box transcription factor 2
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 3:181,711,925...181,714,436
Ensembl chr 3:181,711,925...181,714,436
G
SPI1
Spi-1 proto-oncogene
treatment
ISO
protein:decreased expression:alveolar macrophage
RGD
PMID:16272341 PMID:21447000
RGD:9586723 , RGD:9586725
NCBI chr11:47,354,860...47,378,547
Ensembl chr11:47,354,860...47,409,369
G
SPN
sialophorin
ISO
associated with Prenatal Exposure Delayed Effects and anxiety disorder:DNA:Hypermthylation:promoter
RGD
PMID:30016666
RGD:401959614
NCBI chr16:29,662,963...29,670,876
Ensembl chr16:29,662,979...29,670,876
G
ST6GAL1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
severity
IEP
mRNA,protein:decreased expression:liver:
RGD
PMID:17697868
RGD:10043133
NCBI chr 3:186,930,526...187,078,553
Ensembl chr 3:186,930,325...187,078,553
G
SYP
synaptophysin
sexual_dimorphism
ISO
associated with chronic stress in female rats
RGD
PMID:27894930
RGD:401959751
NCBI chr X:49,187,815...49,200,193
Ensembl chr X:49,187,815...49,200,218
G
TACR1
tachykinin receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19204064
NCBI chr 2:75,046,463...75,199,520
Ensembl chr 2:75,046,463...75,199,520
G
TACR3
tachykinin receptor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422838
NCBI chr 4:103,586,031...103,719,985
Ensembl chr 4:103,586,031...103,719,985
G
TAS2R16
taste 2 receptor member 16
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16385453 PMID:17250611
NCBI chr 7:122,994,704...122,995,700
Ensembl chr 7:122,994,704...122,995,700
G
TAS2R38
taste 2 receptor member 38
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17250611
NCBI chr 7:141,972,631...141,973,773
Ensembl chr 7:141,972,631...141,973,773
G
TBX19
T-box transcription factor 19
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 1:168,280,877...168,314,426
Ensembl chr 1:168,280,877...168,314,426
G
TF
transferrin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11000917 PMID:21792595
NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
G
TIMELESS
timeless circadian regulator
susceptibility
IAGP
DNA:SNP:: (rs2291738) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr12:56,416,363...56,449,426
Ensembl chr12:56,416,363...56,449,426
G
TPH1
tryptophan hydroxylase 1
IAGP
RGD
PMID:15654285
RGD:1580464
NCBI chr11:18,017,555...18,046,269
Ensembl chr11:18,017,555...18,046,269
G
VIP
vasoactive intestinal peptide
susceptibility
IAGP
DNA:SNPs, haplotype:: (rs3823082,rs688136) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 6:152,750,797...152,759,760
Ensembl chr 6:152,750,797...152,759,765
G
CCK
cholecystokinin
susceptibility
IAGP
DNA:SNP:promoter: -45C>T (human)
RGD
PMID:10235270
RGD:406351024
NCBI chr 3:42,257,826...42,266,185
Ensembl chr 3:42,257,825...42,266,185
G
CNR1
cannabinoid receptor 1
IAGP
RGD
PMID:11841893
RGD:1626329
NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
G
NGF
nerve growth factor
IEP
protein:increased expression:serum
RGD
PMID:17434673
RGD:401965399
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:16318954
RGD:5688289
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
SLC6A3
solute carrier family 6 member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
G
CACNA1D
calcium voltage-gated channel subunit alpha1 D
susceptibility
ISO
mRNA, protein:increased expression:inferior colliculus (rat)
RGD
PMID:25556199
RGD:152985539
NCBI chr 3:53,494,611...53,813,733
Ensembl chr 3:53,328,963...53,813,733
G
DRD2
dopamine receptor D2
susceptibility
IAGP
DNA:SNP:exon:A>G(human)
RGD
PMID:23238469
RGD:401959213
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
PDYN
prodynorphin
ISO
mRNA:increased expression:brain
RGD
PMID:15869750
RGD:401850576
NCBI chr20:1,978,756...1,994,285
Ensembl chr20:1,978,757...1,994,285
G
SLC29A1
solute carrier family 29 member 1 (Augustine blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283641
NCBI chr 6:44,219,615...44,234,142
Ensembl chr 6:44,219,553...44,234,142
G
SLC6A3
solute carrier family 6 member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
G
BDNF
brain derived neurotrophic factor
severity
IEP
RGD
PMID:20553781
RGD:405849399
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BMAL1
basic helix-loop-helix ARNT like 1
severity
IEP
mRNA:decreased expression:peripheral blood mononuclear cells (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,652...13,387,266
G
CLOCK
clock circadian regulator
severity
IEP
mRNA:decreased expression:peripheral blood mononuclear cells (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr 4:55,427,903...55,546,909
Ensembl chr 4:55,427,903...55,546,909
G
CRY1
cryptochrome circadian regulator 1
severity
IEP
mRNA:decreased expression:peripheral blood mononuclear cells (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr12:106,991,364...107,093,549
Ensembl chr12:106,991,364...107,093,549
G
CRY2
cryptochrome circadian regulator 2
IEP
mRNA:decreased expression:Peripheral blood mononuclear cell (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr11:45,847,118...45,883,244
Ensembl chr11:45,847,118...45,883,248
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
no_association treatment
IAGP
DNA:SNPs::CYP2C19*2 (681G>A,rs4244285), CYP2C19*3 (636G>A, rs4986893),CYP2C19*17 (-806C>T, rs12248560) (human) DNA:SNP:promoter:CYP2C19*17 (-806C>T,rs12248560)(human) DNA:SNP:cds:CYP2C19*2 (681G>A,rs4244285)(human)
RGD
PMID:27099220 PMID:30325732 PMID:31957548
RGD:401960863 , RGD:401960882 , RGD:401960880
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
DRD4
dopamine receptor D4
severity
IAGP
DNA:repeats:exon:
RGD
PMID:20359751
RGD:401959612
NCBI chr11:637,269...640,706
Ensembl chr11:637,269...640,706
G
FKBP5
FKBP prolyl isomerase 5
severity
IAGP
DNA:SNPs,haplotypes:multiple
RGD
PMID:24603855
RGD:401976481
NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,573,585...35,728,583
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
ISO
protein:altered expression:brain
RGD
PMID:26727528 PMID:31778691
RGD:405101372 , RGD:405255665
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FOSB
FosB proto-oncogene, AP-1 transcription factor subunit
disease_progression
ISO
protein:increased expression:primary motor cortex, secondary motor cortex, ventral tegmental area (mouse)
RGD
PMID:24355551
RGD:401851085
NCBI chr19:45,467,996...45,475,179
Ensembl chr19:45,467,995...45,475,179
G
GABRG2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA, protein:increased expression:hippocampus (rat)
RGD
PMID:12488536
RGD:402528882
NCBI chr 5:162,067,465...162,155,539
Ensembl chr 5:162,000,057...162,162,977
G
GDNF
glial cell derived neurotrophic factor
ISO
mRNA, DNA:altered expression, hypomethylation:brain
RGD
PMID:31710958
RGD:405820205
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
GRIA1
glutamate ionotropic receptor AMPA type subunit 1
ISO
protein:increased phosphorylation:lateral habenular nucleus (rat)
RGD
PMID:28865912
RGD:405650672
NCBI chr 5:153,489,615...153,813,869
Ensembl chr 5:153,489,615...153,813,869
G
NGF
nerve growth factor
IEP
protein:increased expression:plasma
RGD
PMID:8727238
RGD:401976550
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NPY1R
neuropeptide Y receptor Y1
ISO
mRNA:decreased expression:hippocampus, cerebral cortex (rat)
RGD
PMID:20028355
RGD:10448926
NCBI chr 4:163,323,962...163,344,689
Ensembl chr 4:163,323,962...163,344,832
G
PER1
period circadian regulator 1
severity
IEP
mRNA:decreased expression:peripheral blood mononuclear cells (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr17:8,140,472...8,152,404
Ensembl chr17:8,140,472...8,156,506
G
PER2
period circadian regulator 2
severity
IEP
mRNA:decreased expression:Peripheral blood mononuclear cell (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102
G
POMC
proopiomelanocortin
ISO
mRNA:increased expression:hypothalamus protein:decreased expression:plasma
RGD
PMID:11981131 PMID:31117084
RGD:407424597 , RGD:407431638
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
PRL
prolactin
treatment
IEP
RGD
PMID:3816539
RGD:401960110
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
G
AIF1
allograft inflammatory factor 1
ISO
protein:increased expression:cortex, hippocampus (rat)
RGD
PMID:18585922
RGD:2313030
NCBI chr 6:31,615,234...31,617,015
Ensembl chr 6:31,615,217...31,617,021
G
CIRBP
cold inducible RNA binding protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24223948
NCBI chr19:1,269,332...1,274,880
Ensembl chr19:1,259,384...1,274,880
G
ALDH2
aldehyde dehydrogenase 2 family member
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ANKK1
ankyrin repeat and kinase domain containing 1
IAGP
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr11:113,387,779...113,400,416
Ensembl chr11:113,387,779...113,400,416
G
DRD2
dopamine receptor D2
IAGP
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
FOXO4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:71,095,851...71,103,532
Ensembl chr X:71,095,851...71,103,532
G
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
HECTD4
HECT domain E3 ubiquitin protein ligase 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr12:112,160,195...112,382,431
Ensembl chr12:112,160,188...112,382,439
G
PPA2
inorganic pyrophosphatase 2
IAGP
ClinVar Annotator: match by term: Sudden cardiac failure, alcohol-induced
OMIM ClinVar
PMID:24033266 PMID:25741868 PMID:27523597 PMID:27523598 PMID:28492532 PMID:30384889 PMID:31705601 PMID:33028643 PMID:34400813 More...
NCBI chr 4:105,369,077...105,474,070
Ensembl chr 4:105,369,077...105,474,067
G
ACE
angiotensin I converting enzyme
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
AGT
angiotensinogen
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22497828
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
NOS1
nitric oxide synthase 1
ISO
protein:decreased expression:skeletal muscle, membrane
RGD
PMID:17607508
RGD:1642138
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:heart myocardium
RGD
PMID:18783396
RGD:2301868
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
RXRA
retinoid X receptor alpha
ISO
RGD
PMID:19791468
RGD:2317465
NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585
G
SLC25A4
solute carrier family 25 member 4
ISO
mRNA, protein:decreased expression:myocardium
RGD
PMID:21169901
RGD:9681464
NCBI chr 4:185,143,266...185,150,382
Ensembl chr 4:185,143,266...185,150,382
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
IEP
protein:increased expression:plasma
RGD
PMID:16115302
RGD:5686674
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADIPOR2
adiponectin receptor 2
treatment
ISO
RGD
PMID:26115886 PMID:18755807 PMID:27220557 PMID:22013387
RGD:25330099 , RGD:25824943 , RGD:25824939 , RGD:25440493
NCBI chr12:1,691,070...1,788,674
Ensembl chr12:1,688,574...1,788,674
G
ADRA2A
adrenoceptor alpha 2A
IEP
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chr10:111,077,029...111,080,907
Ensembl chr10:111,077,029...111,080,907
G
ALDH2
aldehyde dehydrogenase 2 family member
susceptibility treatment severity
ISO IAGP IMP
DNA:missense mutation:cds:p.E504K (human) protein:altered processing:liver (mouse) human transgene in mouse model
RGD
PMID:17058263 PMID:29063269 PMID:29156373 PMID:25457208
RGD:1599041 , RGD:14696776 , RGD:15036805 , RGD:15036811
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
AR
androgen receptor
severity
ISO
RGD
PMID:11447013
RGD:407424619
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
ARRB2
arrestin beta 2
ameliorates
IEP ISO
protein:increased expression:hepatocyte
RGD
PMID:33871024 PMID:33871024
RGD:401938594 , RGD:401938594
NCBI chr17:4,710,632...4,721,497
Ensembl chr17:4,710,596...4,721,499
G
ATG7
autophagy related 7
exacerbates ameliorates
ISO
RGD
PMID:31235522 PMID:34303881
RGD:407445921 , RGD:407445922
NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665
G
BIRC3
baculoviral IAP repeat containing 3
IEP
protein:increased expression:liver (human)
RGD
PMID:29307797
RGD:153297819
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
G
C1QC
complement C1q C chain
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:35789393
NCBI chr 1:22,643,633...22,648,108
Ensembl chr 1:22,643,014...22,648,110
G
CCL2
C-C motif chemokine ligand 2
treatment
ISO
RGD
PMID:25557254 PMID:30611703
RGD:14995489 , RGD:407424594
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCR2
C-C motif chemokine receptor 2
treatment
ISO
RGD
PMID:25557254
RGD:14995489
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR5
C-C motif chemokine receptor 5
disease_progression
ISO
RGD
PMID:27859576
RGD:14401742
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CD14
CD14 molecule
treatment
ISO
RGD
PMID:23277536
RGD:407424596
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD36
CD36 molecule (CD36 blood group)
ISO
RGD
PMID:24280415
RGD:11041117
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CD68
CD68 molecule
treatment
ISO
RGD
PMID:23277536 PMID:29399060
RGD:407424596 , RGD:407424599
NCBI chr17:7,579,638...7,582,111
Ensembl chr17:7,579,491...7,582,111
G
CRP
C-reactive protein
ISO
protein:increased expression:serum:
RGD
PMID:21806828
RGD:9491781
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CTSB
cathepsin B
ISO
protein:increased activity:liver, cytosol (rat)
RGD
PMID:17850215
RGD:2315516
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
CXCL1
C-X-C motif chemokine ligand 1
ameliorates
ISO
RGD
PMID:33710653
RGD:401976495
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:26428356 PMID:25583360 PMID:24064383
RGD:14700884 , RGD:14700870
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
DNMT1
DNA methyltransferase 1
ISO
RGD
PMID:22905112
RGD:9588654
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
G
FKBP5
FKBP prolyl isomerase 5
ameliorates
IEP ISO
mRNA,protein:incrased expression:liver (human)
RGD
PMID:33710653 PMID:33710653
RGD:401976495 , RGD:401976495
NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,573,585...35,728,583
G
FOXO1
forkhead box O1
IEP
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641
G
HAMP
hepcidin antimicrobial peptide
ISO
mRNA:decreased expression:liver
RGD
PMID:19253830
RGD:11041633
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
G
LBP
lipopolysaccharide binding protein
treatment
ISO
RGD
PMID:23277536
RGD:407424596
NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,013
G
LDLR
low density lipoprotein receptor
IEP
protein:decreased expression: liver (rat)
RGD
PMID:20028367
RGD:21410185
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
MIR155
microRNA 155
ISO
RGD
PMID:26867493
RGD:25671474
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
NLRC5
NLR family CARD domain containing 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:36708882
NCBI chr16:56,989,557...57,083,520
Ensembl chr16:56,989,485...57,083,531
G
NR1H3
nuclear receptor subfamily 1 group H member 3
treatment
ISO
RGD
PMID:26256083
RGD:11522097
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
G
OCLN
occludin
treatment
ISO
RGD
PMID:31116255
RGD:407424600
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
G
PEMT
phosphatidylethanolamine N-methyltransferase
ISO
RGD
PMID:17156888
RGD:1642369
NCBI chr17:17,505,563...17,592,142
Ensembl chr17:17,505,563...17,591,708
G
PPARA
peroxisome proliferator activated receptor alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18703563
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
RELA
RELA proto-oncogene, NF-kB subunit
treatment
ISO
RGD
PMID:29399060 PMID:31116255
RGD:407424599 , RGD:407424600
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
SERPINE1
serpin family E member 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:25561792
RGD:11075083
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SERPINF1
serpin family F member 1
ISO
protein:decreased expression:liver
RGD
PMID:18996124
RGD:2312349
NCBI chr17:1,762,060...1,777,565
Ensembl chr17:1,762,029...1,777,565
G
SOD1
superoxide dismutase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19951287
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
ISO
RGD
PMID:11477087
RGD:1625694
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
STAT4
signal transducer and activator of transcription 4
ISO
RGD
PMID:18296740
RGD:7207884
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,178,435
G
TEAD1
TEA domain transcription factor 1
ameliorates
ISO
RGD
PMID:33710653
RGD:401976495
NCBI chr11:12,674,421...12,944,737
Ensembl chr11:12,674,421...12,944,737
G
TGFB1
transforming growth factor beta 1
treatment
ISO
RGD
PMID:29399060
RGD:407424599
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TJP1
tight junction protein 1
treatment
ISO
RGD
PMID:23277536
RGD:407424596
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
G
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:23277536
RGD:407424596
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
G
TLR4
toll like receptor 4
severity treatment
ISO
RGD
PMID:29884546 PMID:23277536 PMID:21463341
RGD:14697697 , RGD:407424596 , RGD:14700554
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
susceptibility treatment
IAGP ISO
DNA:SNP:promoter:-238G>A (human)
RGD
PMID:9214463 PMID:29399060 PMID:20143470
RGD:14995434 , RGD:407424599 , RGD:38508901
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
UBD
ubiquitin D
IEP
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chr 6:29,555,515...29,559,732
Ensembl chr 6:29,555,515...29,559,732
G
ABCB11
ATP binding cassette subfamily B member 11
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
AGT
angiotensinogen
IEP
mRNA:decreased expression:liver
RGD
PMID:17258719
RGD:1601135
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AHR
aryl hydrocarbon receptor
IEP
protein:altered expression:hepatocyte
RGD
PMID:34082111
RGD:405866379
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
ALB
albumin
severity
IEP
protein:increased expression, modification:urine
RGD
PMID:29369844
RGD:14694842
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ATG7
autophagy related 7
ISO
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665
G
BECN1
beclin 1
ISO
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
G
CCL2
C-C motif chemokine ligand 2
severity
IEP ISO
RNA:increased expression:liver:
RGD
PMID:24429361 PMID:21826694 PMID:10446112
RGD:14975280 , RGD:14995491 , RGD:14995467
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL3
C-C motif chemokine ligand 3
severity
IEP
RGD
PMID:10446112
RGD:14995467
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
G
CCL5
C-C motif chemokine ligand 5
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12586603 PMID:31258651
RGD:14995304
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
COL1A1
collagen type I alpha 1 chain
IEP
RGD
PMID:1670041
RGD:5688335
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
CPT1A
carnitine palmitoyltransferase 1A
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
G
CXCL8
C-X-C motif chemokine ligand 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26220752
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
DDR1
discoidin domain receptor tyrosine kinase 1
disease_progression severity
ISO IEP
mRNA:increased expression:liver (mouse) mRNA:increased expression:liver (human)
RGD
PMID:33173221 PMID:33173221
RGD:151347691 , RGD:151347691
NCBI chr 6:30,880,970...30,900,156
Ensembl chr 6:30,876,421...30,900,156
G
FAS
Fas cell surface death receptor
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FGF19
fibroblast growth factor 19
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr11:69,698,238...69,704,022
Ensembl chr11:69,698,238...69,704,022
G
ICAM1
intercellular adhesion molecule 1
severity
IEP
protein:increased expression:hepatocyte
RGD
PMID:1347281
RGD:14402038
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IL13
interleukin 13
ISO
mRNA:increased expression:liver
RGD
PMID:16698589
RGD:1581860
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL18
interleukin 18
severity
IEP
associated alcoholic liver cirrhosis; protein:increased expression:plasma:
RGD
PMID:15566508
RGD:14696666
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
MIR155
microRNA 155
ameliorates
ISO
RNA:increased expression:liver
RGD
PMID:32317960 PMID:31090940
RGD:151347420 , RGD:407445926
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MTOR
mechanistic target of rapamycin kinase
ISO
protein:decreased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
NFKB1
nuclear factor kappa B subunit 1
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NFKBIA
NFKB inhibitor alpha
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NLRP3
NLR family pyrin domain containing 3
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
G
NQO1
NAD(P)H quinone dehydrogenase 1
IEP
protein:altered expression:hepatocyte
RGD
PMID:34082111
RGD:405866379
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR0B2
nuclear receptor subfamily 0 group B member 2
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
NR1H4
nuclear receptor subfamily 1 group H member 4
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
G
PPARA
peroxisome proliferator activated receptor alpha
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
SLC10A1
solute carrier family 10 member 1
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
G
SOCS1
suppressor of cytokine signaling 1
ISO
mRNA:decreased expression:liver
RGD
PMID:32317960
RGD:151347420
NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204
G
SQSTM1
sequestosome 1
ISO
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
SREBF1
sterol regulatory element binding transcription factor 1
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
STS
steroid sulfatase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26220752
NCBI chr X:7,147,290...7,354,641
Ensembl chr X:7,147,237...7,804,358
G
SULT1E1
sulfotransferase family 1E member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26220752
NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145
G
TNF
tumor necrosis factor
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12586603 PMID:27939985
RGD:15036816
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
ARC
activity regulated cytoskeleton associated protein
disease_progression
ISO
mRNA:altered expression:brain (mouse)
RGD
PMID:26708208
RGD:401853772
NCBI chr 8:142,611,049...142,614,479
Ensembl chr 8:142,611,049...142,614,479
G
BDNF
brain derived neurotrophic factor
ISO
mRNA,protein:decreased expression:cerebellum
RGD
PMID:19861148
RGD:401965398
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
DRD2
dopamine receptor D2
treatment
ISO
RGD
PMID:28300818
RGD:13506954
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
protein:altered expression:brain mRNA:decreased expression:adrenal gland
RGD
PMID:26727528 PMID:12351928
RGD:405101372 , RGD:405255666
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
GDNF
glial cell derived neurotrophic factor
ISO
mRNA:decreased expression:basal nucleus
RGD
PMID:24061482
RGD:405850213
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
IFNG
interferon gamma
treatment
ISO
RGD
PMID:9514301
RGD:10755766
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
NGF
nerve growth factor
ISO IEP
mRNA,protein:increased expression:cerebellum protein:increased expression:plasma
RGD
PMID:19861148 PMID:18639986
RGD:401965398 , RGD:401965411
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NPS
neuropeptide S
ISO
RGD
PMID:19860802
RGD:9831199
NCBI chr10:127,549,309...127,553,540
Ensembl chr10:127,549,309...127,553,540
G
NPSR1
neuropeptide S receptor 1
ISO
mRNA:increased expression:brain
RGD
PMID:19860802
RGD:9831199
NCBI chr 7:34,658,218...34,878,332
Ensembl chr 7:34,658,218...34,878,332
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
mRNA,protein:increased expression:cerebellum
RGD
PMID:19861148
RGD:401965398
NCBI chr 1:156,815,750...156,881,850
Ensembl chr 1:156,815,636...156,881,850
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ISO
mRNA:increased expression:basal nucleus, cerebral cortex
RGD
PMID:24061482
RGD:405850213
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
PER2
period circadian regulator 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15608650
NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102
G
ALDH2
aldehyde dehydrogenase 2 family member
susceptibility
IAGP
DNA:missense mutation:cds:p.E504K (human) DNA:missense mutation:cds: (rs671) (human) associated with alcohol dependence;DNA:missense mutation:exon 12:p.E487K (human)
RGD
PMID:29779728 PMID:23550892 PMID:11051375
RGD:14696777 , RGD:15042864 , RGD:15042858
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
BCL2
BCL2 apoptosis regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
CAT
catalase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
IEP
protein:decreased expression:brain
RGD
PMID:16205370
RGD:6483345
NCBI chr17:41,966,795...41,977,740
Ensembl chr17:41,966,763...41,977,740
G
COL3A1
collagen type III alpha 1 chain
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
G
CRP
C-reactive protein
severity
IEP
RGD
PMID:22441510
RGD:6482305
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
EXP IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20843640 PMID:29404441
RGD:14700873
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
DDR1
discoidin domain receptor tyrosine kinase 1
severity
IEP
mRNA:increased expression:liver (human)
RGD
PMID:33173221
RGD:151347691
NCBI chr 6:30,880,970...30,900,156
Ensembl chr 6:30,876,421...30,900,156
G
DDR2
discoidin domain receptor tyrosine kinase 2
disease_progression ameliorates
ISO
RGD
PMID:21199726 PMID:23409069
RGD:150429766 , RGD:150517731
NCBI chr 1:162,630,863...162,787,405
Ensembl chr 1:162,631,373...162,787,405
G
FABP2
fatty acid binding protein 2
onset
IAGP
DNA:polymorphism:CDS:amino acid A54T, homozygosity of the T allele associated with later onset
RGD
PMID:16289894
RGD:1578455
NCBI chr 4:119,317,250...119,322,138
Ensembl chr 4:119,317,250...119,322,138
G
GABRG2
gamma-aminobutyric acid type A receptor subunit gamma2
susceptibility
IAGP
DNA:SNP:intron 8:84435G>A (human)
RGD
PMID:19428381
RGD:402463950
NCBI chr 5:162,067,465...162,155,539
Ensembl chr 5:162,000,057...162,162,977
G
IL18BP
interleukin 18 binding protein
IEP
protein:increased expression:plasma:
RGD
PMID:15566508
RGD:14696666
NCBI chr11:71,998,909...72,008,200
Ensembl chr11:71,998,613...72,007,315
G
IL6
interleukin 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
JAK2
Janus kinase 2
IEP
mRNA, protein:increased expression, increased tyrosine phosphorylation:liver
RGD
PMID:24619965
RGD:10403061
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
LEP
leptin
IDA
DNA:hypomethylation:promoter (human)
RGD
PMID:29912265
RGD:21201248
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
MBOAT7
membrane bound O-acyltransferase domain containing 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26482880
NCBI chr19:54,173,415...54,189,580
Ensembl chr19:54,173,412...54,189,882
G
MIR122
microRNA 122
IEP
miRNA:decreased expression:liver
RGD
PMID:28987423
RGD:14401600
NCBI chr18:58,451,074...58,451,158
Ensembl chr18:58,451,074...58,451,158
G
MIR141
microRNA 141
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr12:6,964,097...6,964,191
Ensembl chr12:6,964,097...6,964,191
G
MIR17
microRNA 17
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr13:91,350,605...91,350,688
Ensembl chr13:91,350,605...91,350,688
G
MIR193B
microRNA 193b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:14,303,967...14,304,049
Ensembl chr16:14,303,967...14,304,049
G
MIR338
microRNA 338
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:81,125,883...81,125,949
Ensembl chr17:81,125,883...81,125,949
G
MIR3615
microRNA 3615
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:74,748,613...74,748,699
Ensembl chr17:74,748,613...74,748,699
G
MIR421
microRNA 421
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:74,218,377...74,218,461
Ensembl chr X:74,218,377...74,218,461
G
MIR423
microRNA 423
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:30,117,079...30,117,172
Ensembl chr17:30,117,079...30,117,172
G
MIR483
microRNA 483
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:2,134,134...2,134,209
Ensembl chr11:2,134,134...2,134,209
G
MIR484
microRNA 484
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:15,643,294...15,643,372
Ensembl chr16:15,643,294...15,643,372
G
MIR532
microRNA 532
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:50,003,148...50,003,238
Ensembl chr X:50,003,148...50,003,238
G
MIR589
microRNA 589
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:5,495,819...5,495,917
Ensembl chr 7:5,495,819...5,495,917
G
MIR629
microRNA 629
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr15:70,079,372...70,079,468
Ensembl chr15:70,079,372...70,079,468
G
MIR885
microRNA 885
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 3:10,394,489...10,394,562
Ensembl chr 3:10,394,489...10,394,562
G
MIR93
microRNA 93
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:100,093,768...100,093,847
Ensembl chr 7:100,093,768...100,093,847
G
MMP13
matrix metallopeptidase 13
ISO
RGD
PMID:16286264
RGD:10043176
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
G
MMP2
matrix metallopeptidase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MPO
myeloperoxidase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19731237 PMID:23274713
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MTHFR
methylenetetrahydrofolate reductase
susceptibility
IAGP
DNA:SNP: :677C>T(human)
RGD
PMID:25987440
RGD:14696749
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
NR1D1
nuclear receptor subfamily 1 group D member 1
IEP
RGD
PMID:24497272
RGD:10448995
NCBI chr17:40,092,793...40,100,589
Ensembl chr17:40,092,793...40,100,589
G
PLAU
plasminogen activator, urokinase
ISO
RGD
PMID:19615318
RGD:7241800
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PNPLA3
patatin like phospholipase domain containing 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19946271 PMID:26482880
NCBI chr22:43,923,805...43,947,582
Ensembl chr22:43,923,792...43,964,488
G
RELA
RELA proto-oncogene, NF-kB subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
SERPINE1
serpin family E member 1
susceptibility
IAGP
DNA:polymorphism:promoter:
RGD
PMID:25987440
RGD:14696749
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SERPINF1
serpin family F member 1
IEP
protein:increased expression:serum (human)
RGD
PMID:27748324
RGD:27226704
NCBI chr17:1,762,060...1,777,565
Ensembl chr17:1,762,029...1,777,565
G
SMAD3
SMAD family member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
G
SOD2
superoxide dismutase 2
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:SNP: : 47T>C(human)
CTD RGD
PMID:19731237 PMID:26873981
RGD:11060603
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
TG
thyroglobulin
IDA
RGD
PMID:6883738
RGD:401976502
NCBI chr 8:132,866,958...133,134,899
Ensembl chr 8:132,866,958...133,134,903
G
TGFB1
transforming growth factor beta 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TIMP1
TIMP metallopeptidase inhibitor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
TLR9
toll like receptor 9
IEP
protein:increased expression:blood, neutrophil (human)
RGD
PMID:18433921
RGD:5130706
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
TM6SF2
transmembrane 6 superfamily member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26482880
NCBI chr19:19,264,366...19,273,301
Ensembl chr19:19,264,364...19,273,391
G
TNF
tumor necrosis factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
ACE
angiotensin I converting enzyme
severity treatment
IEP IMP
protein:increased activity:serum (human)
RGD
PMID:3028446 PMID:28691216
RGD:19165343 , RGD:40400719
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ADIPOR2
adiponectin receptor 2
treatment
ISO
RGD
PMID:24797033
RGD:25824940
NCBI chr12:1,691,070...1,788,674
Ensembl chr12:1,688,574...1,788,674
G
AHR
aryl hydrocarbon receptor
exacerbates ameliorates
ISO
RGD
PMID:34454169 PMID:36871955
RGD:405866377 , RGD:405866378
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
ALDH2
aldehyde dehydrogenase 2 family member
susceptibility severity
IAGP ISO
DNA:missense mutation:cds, exon 12:p.E487K (human) DNA:polymorphism:exon 12: (human) DNA:deletion:cds: (mouse)
RGD
PMID:1916152 PMID:12198368 PMID:26173414 PMID:3189338
RGD:14696699 , RGD:14981580 , RGD:11076022 , RGD:14696790
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ANGPT2
angiopoietin 2
severity
IEP
RGD
PMID:24959006
RGD:15014784
NCBI chr 8:6,499,632...6,563,245
Ensembl chr 8:6,499,632...6,563,409
G
ATG7
autophagy related 7
ISO
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665
G
BECN1
beclin 1
ISO
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
G
C6
complement C6
resistance
ISO
RGD
PMID:15351314
RGD:1600673
NCBI chr 5:41,142,116...41,261,469
Ensembl chr 5:41,142,116...41,261,438
G
CAT
catalase
treatment
ISO
RGD
PMID:8370342 PMID:28898587
RGD:405255646 , RGD:405255658
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CAV1
caveolin 1
treatment
ISO
RGD
PMID:23764359
RGD:8662277
NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
G
CD27
CD27 molecule
ISO
RGD
PMID:16698589
RGD:1581860
NCBI chr12:6,443,892...6,451,713
Ensembl chr12:6,444,955...6,451,718
G
CD59
CD59 molecule (CD59 blood group)
ISO
protein:decreased expression:liver
RGD
PMID:12483994
RGD:1600486
NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479
G
CLDN1
claudin 1
treatment
ISO
RGD
PMID:31116255
RGD:407424600
NCBI chr 3:190,305,707...190,322,446
Ensembl chr 3:190,305,707...190,322,446
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
susceptibility
IAGP
DNA:SNP::-318 T>C(rs5742909)(human)
RGD
PMID:15208156
RGD:14398728
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
mRNA:increased expression:liver
RGD
PMID:10498645
RGD:5135271
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL2
C-X-C motif chemokine ligand 2
ISO
mRNA:increased expression:liver
RGD
PMID:10498645
RGD:5135271
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL5
C-X-C motif chemokine ligand 5
ISO
mRNA:increased expression:liver
RGD
PMID:10498645
RGD:5135271
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
CXCL6
C-X-C motif chemokine ligand 6
ISO
mRNA:increased expression:liver
RGD
PMID:10498645
RGD:5135271
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
treatment
IEP IDA ISO
RGD
PMID:29401608 PMID:9927612 PMID:30192013 PMID:25592162 PMID:29902864
RGD:14700887 , RGD:405650696 , RGD:14700906 , RGD:14700894 , RGD:14700893
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
IDA
RGD
PMID:9927612
RGD:405650696
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
EGFR
epidermal growth factor receptor
ISO
RGD
PMID:30502657
RGD:38599215
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
EIF2S1
eukaryotic translation initiation factor 2 subunit alpha
ISO
RGD
PMID:21059295
RGD:10395351
NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,328...67,386,516
G
FAS
Fas cell surface death receptor
IEP
protein:increased expression:lymphocyte:
RGD
PMID:26429926
RGD:14700711
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
GDNF
glial cell derived neurotrophic factor
IEP ISO
protein:increased expression:serum mRNA,protein:increased expression:liver
RGD
PMID:35338490 PMID:35338490
RGD:405849393 , RGD:405849393
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
GSTM1
glutathione S-transferase mu 1
IAGP
RGD
PMID:15932176 PMID:26937962
RGD:14700973 , RGD:11060494
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTT1
glutathione S-transferase theta 1
IAGP
RGD
PMID:15932176 PMID:26937962
RGD:14700973 , RGD:11060494
G
HFE
homeostatic iron regulator
ISO
mRNA:increased expression:liver, Kupffer cell (rat)
RGD
PMID:18599584
RGD:8694397
NCBI chr 6:26,087,429...26,098,343
Ensembl chr 6:26,087,226...26,098,343
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:17085342
RGD:9068897
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
IGF2
insulin like growth factor 2
ISO
mRNA:increased expression:liver
RGD
PMID:18505416
RGD:5510002
NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
G
IL1B
interleukin 1 beta
ISO
protein:increased expression:serum (rat)
RGD
PMID:23009062
RGD:7204488
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL6
interleukin 6
treatment
ISO
RGD
PMID:31116255
RGD:407424600
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
KEAP1
kelch like ECH associated protein 1
IEP
mRNA:decreased expression:liver (human)
RGD
PMID:22459801
RGD:6892954
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
G
LPL
lipoprotein lipase
treatment
ISO
RGD
PMID:28442378
RGD:13794376
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
G
MIF
macrophage migration inhibitory factor
ISO
protein:increased expression:liver
RGD
PMID:11798463
RGD:1642007
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
MIR122
microRNA 122
ISO
miRNA:decreased expression:hepatocyte
RGD
PMID:28987423
RGD:14401600
NCBI chr18:58,451,074...58,451,158
Ensembl chr18:58,451,074...58,451,158
G
MIR155
microRNA 155
ameliorates
ISO IEP
RNA:increased expression:liver
RGD
PMID:28492308 PMID:31090940 PMID:31090940
RGD:25314298 , RGD:407445926 , RGD:407445926
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR223
microRNA 223
severity
ISO
RGD
PMID:27679493
RGD:21408575
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
G
MMP9
matrix metallopeptidase 9
ISO
protein:increased expression:liver
RGD
PMID:17374579
RGD:1642042
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MTOR
mechanistic target of rapamycin kinase
ISO IEP
protein:decreased expression:liver
RGD
PMID:31090940 PMID:31090940
RGD:407445926 , RGD:407445926
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
MYC
MYC proto-oncogene, bHLH transcription factor
disease_progression severity
IEP ISO
mRNA:increased expression:liver
RGD
PMID:26576483 PMID:26576483
RGD:14695016 , RGD:14695016
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
NEDD8
NEDD8 ubiquitin like modifier
IEP
RGD
PMID:12533840
RGD:1549458
NCBI chr14:24,216,857...24,232,367
Ensembl chr14:24,216,857...24,232,367
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment severity
ISO IAGP
DNA:SNP:promoter:rs35652124(human)
RGD
PMID:31906014 PMID:31340446
RGD:21201307 , RGD:21201311
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NQO1
NAD(P)H quinone dehydrogenase 1
ameliorates
ISO
RGD
PMID:34082111
RGD:405866379
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
OTC
ornithine transcarbamylase
ISO
protein:increased expression:serum (rat)
RGD
PMID:19101528
RGD:4144059
NCBI chr X:38,327,684...38,422,928
Ensembl chr X:38,327,598...38,422,908
G
PLAUR
plasminogen activator, urokinase receptor
IEP
protein:increased expression:serum
RGD
PMID:22098627
RGD:6484116
NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547
G
PNPLA3
patatin like phospholipase domain containing 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19946271
NCBI chr22:43,923,805...43,947,582
Ensembl chr22:43,923,792...43,964,488
G
PPARA
peroxisome proliferator activated receptor alpha
severity
ISO
DNA:knockout::increased severity in knockouts (mouse)
RGD
PMID:15382117
RGD:5683636
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARD
peroxisome proliferator activated receptor delta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27765815
NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191
G
PSMD14
proteasome 26S subunit, non-ATPase 14
ISO
protein:decreased expression:liver, cytosolic proteasome complex (rat)
RGD
PMID:19609968
RGD:9480236
NCBI chr 2:161,308,425...161,411,717
Ensembl chr 2:161,308,425...161,411,717
G
RBP4
retinol binding protein 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762690
NCBI chr10:93,591,694...93,601,744
Ensembl chr10:93,591,687...93,601,744
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
protein:increased phosphorylation:liver
RGD
PMID:35338490
RGD:405849393
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
SLC39A13
solute carrier family 39 member 13
ISO
protein:increased expression:liver, endoplasmic reticulum (rat)
RGD
PMID:25767260
RGD:11553884
NCBI chr11:47,407,276...47,416,500
Ensembl chr11:47,407,132...47,416,496
G
SOD1
superoxide dismutase 1
treatment
IMP
human gene in a rat model
RGD
PMID:11266387
RGD:9587792
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
treatment
ISO
RGD
PMID:32236798
RGD:27095880
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SPP1
secreted phosphoprotein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18703563
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SQSTM1
sequestosome 1
ISO IEP
protein:increased expression:liver
RGD
PMID:31090940 PMID:31090940
RGD:407445926 , RGD:407445926
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
TBXAS1
thromboxane A synthase 1
ISO
mRNA,protein:increased expression:liver, Kupffer cell:
RGD
PMID:9262373
RGD:11059607
NCBI chr 7:139,778,242...140,020,293
Ensembl chr 7:139,777,051...140,020,325
G
TERT
telomerase reverse transcriptase
ISO
mRNA,protein,activity:increased expression, increased activity:kupffer cell:
RGD
PMID:26725521
RGD:11574970
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
G
TLR3
toll like receptor 3
treatment
ISO
RGD
PMID:23023014 PMID:30870678
RGD:21079426 , RGD:21079436
NCBI chr 4:186,069,156...186,088,073
Ensembl chr 4:186,068,911...186,088,073
G
TNF
tumor necrosis factor
treatment
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:9397994 PMID:31116255 PMID:7556590 PMID:15670576
RGD:14398736 , RGD:407424600 , RGD:14995472 , RGD:14995456
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
UCHL5
ubiquitin C-terminal hydrolase L5
ISO
protein:decreased expression:liver, cytosolic proteasome complex
RGD
PMID:19609968
RGD:9480236
NCBI chr 1:193,012,254...193,060,076
Ensembl chr 1:193,012,250...193,060,080
G
VEGFA
vascular endothelial growth factor A
IEP
protein:increased expression:plasma
RGD
PMID:24959006
RGD:15014784
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
IGF1
insulin like growth factor 1
ISO
RGD
PMID:23016131
RGD:10402569
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF1R
insulin like growth factor 1 receptor
ISO
RGD
PMID:23016131
RGD:10402569
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
IGF2
insulin like growth factor 2
ISO
RGD
PMID:23016131
RGD:10402569
NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
G
CCK
cholecystokinin
disease_progression
IEP
protein:decreased expression:blood plasma (human)
RGD
PMID:11185710
RGD:407419866
NCBI chr 3:42,257,826...42,266,185
Ensembl chr 3:42,257,825...42,266,185
G
CFTR
CF transmembrane conductance regulator
IAGP
DNA:missense mutations: :p.L1156F, Q1352H (human)
RGD
PMID:26089335
RGD:11566036
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
PTHLH
parathyroid hormone like hormone
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22280800
NCBI chr12:27,958,084...27,972,733
Ensembl chr12:27,958,084...27,972,733
G
UGT1A7
UDP glucuronosyltransferase family 1 member A7
IAGP
DNA:polymorphisms: :p.N129K, p.R131K, p.W208R (human)
RGD
PMID:12806614
RGD:2317503
NCBI chr 2:233,681,901...233,773,300
Ensembl chr 2:233,681,901...233,773,300
G
HTR2A
5-hydroxytryptamine receptor 2A
IAGP
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr13:46,831,546...46,898,082
Ensembl chr13:46,831,546...46,897,076
G
ADH1C
alcohol dehydrogenase 1C (class I), gamma polypeptide
ISO
mRNA:altered exxpression:liver (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 4:99,336,497...99,352,746
Ensembl chr 4:99,336,497...99,352,746
G
ADH4
alcohol dehydrogenase 4 (class II), pi polypeptide
ISO
mRNA:altered exxpression:liver (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 4:99,123,658...99,144,297
Ensembl chr 4:99,123,657...99,157,792
G
BDNF
brain derived neurotrophic factor
ISO
protein:altered expression:amygdala, pyriform cortex, bed nucleus of stria terminalis
RGD
PMID:23588198
RGD:405849391
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
CRHR1
corticotropin releasing hormone receptor 1
ISO
mRNA:decreased expression:adenohypophysis
RGD
PMID:11045867
RGD:407431640
NCBI chr17:45,784,320...45,835,828
Ensembl chr17:45,784,277...45,835,828
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO IDA
mRNA:altered exxpression:liver (rat) protein:increased expression, increased nitration
RGD
PMID:25236742 PMID:23413777 PMID:29404485 PMID:25236742
RGD:14700891 , RGD:405100715 , RGD:14700911 , RGD:14700891
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
DNMT1
DNA methyltransferase 1
ISO
protein:increased expression:nucleus accumbens:
RGD
PMID:23423140
RGD:9588287
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
G
DRD1
dopamine receptor D1
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 5:175,440,036...175,444,182
Ensembl chr 5:175,440,036...175,444,182
G
DRD2
dopamine receptor D2
ISO
mRNA:altered exxpression:spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
DRD3
dopamine receptor D3
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 3:114,127,580...114,199,407
Ensembl chr 3:114,127,580...114,199,407
G
DRD4
dopamine receptor D4
susceptibility
IAGP ISO
DNA:repeats:exon: mRNA:altered exxpression:spleen (rat)
RGD
PMID:19393859 PMID:23413777
RGD:401960068 , RGD:405100715
NCBI chr11:637,269...640,706
Ensembl chr11:637,269...640,706
G
EFHD2
EF-hand domain family member D2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28397836
NCBI chr 1:15,409,888...15,430,339
Ensembl chr 1:15,409,888...15,430,339
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
protein:increased expression:prefrontal cortex
RGD
PMID:29407478
RGD:405295494
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
GABRA1
gamma-aminobutyric acid type A receptor subunit alpha1
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 5:161,847,191...161,899,971
Ensembl chr 5:161,847,063...161,899,981
G
GABRA2
gamma-aminobutyric acid type A receptor subunit alpha2
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 4:46,243,548...46,390,300
Ensembl chr 4:46,243,548...46,475,230
G
GABRA3
gamma-aminobutyric acid type A receptor subunit alpha3
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr X:152,166,234...152,451,315
Ensembl chr X:152,166,234...152,451,315
G
GABRA6
gamma-aminobutyric acid type A receptor subunit alpha6
ISO
mRNA:altered exxpression:spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 5:161,685,721...161,702,592
Ensembl chr 5:161,547,063...161,702,593
G
GDNF
glial cell derived neurotrophic factor
ISO
protein:altered expression:amygdala, pyriform cortex, bed nucleus of stria terminalis
RGD
PMID:23298382 PMID:23588198
RGD:405849390 , RGD:405849391
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
GPX1
glutathione peroxidase 1
ISO
protein:decreased expression:liver
RGD
PMID:25864381
RGD:401827870
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GPX3
glutathione peroxidase 3
ISO
protein:decreased expression:serum
RGD
PMID:25864381
RGD:401827870
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
G
GPX4
glutathione peroxidase 4
ISO
protein:decreased expression:liver
RGD
PMID:25864381
RGD:401827870
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
G
GRM2
glutamate metabotropic receptor 2
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 3:51,707,068...51,718,613
Ensembl chr 3:51,707,068...51,718,613
G
GRM5
glutamate metabotropic receptor 5
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr11:88,504,642...89,065,982
Ensembl chr11:88,504,576...89,065,982
G
MIR125A
microRNA 125a
ISO
RNA:decreased expression:neuron
RGD
PMID:27085842
RGD:26884454
NCBI chr19:51,693,254...51,693,339
Ensembl chr19:51,693,254...51,693,339
G
MIR223
microRNA 223
IEP ISO
RNA:increased expression:serum RNA:increased expression:serum, neutrophil,liver
RGD
PMID:27679493 PMID:27679493
RGD:21408575 , RGD:21408575
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
G
NPY1R
neuropeptide Y receptor Y1
ameliorates
ISO
protein:decreased expression:central amygdaloid nucleus (mouse)
RGD
PMID:30647448 PMID:22218088
RGD:402463940 , RGD:405096664
NCBI chr 4:163,323,962...163,344,689
Ensembl chr 4:163,323,962...163,344,832
G
OPRL1
opioid related nociceptin receptor 1
IDA
RGD
PMID:29197086
RGD:14348965
NCBI chr20:64,080,082...64,100,643
Ensembl chr20:64,080,082...64,100,643
G
PER2
period circadian regulator 2
IEP
DNA, mRNA:hypermethylation, decreased expression:blood
RGD
PMID:30597578
RGD:405878075
NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102
G
POMC
proopiomelanocortin
IEP ISO
DNA, mRNA:hypermethylation, decreased expression:blood mRNA:decreased expression:hypothalamus
RGD
PMID:30597578 PMID:11045867
RGD:405878075 , RGD:407431640
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
SIRT1
sirtuin 1
ISO
RGD
PMID:24416161
RGD:9495933
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
G
SLC23A2
solute carrier family 23 member 2
ISO
RGD
PMID:27085842
RGD:26884454
NCBI chr20:4,852,358...5,010,313
Ensembl chr20:4,852,356...5,010,293
G
ANK3
ankyrin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490
G
APOE
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
BPIFA1
BPI fold containing family A member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr20:33,235,996...33,243,306
Ensembl chr20:33,235,995...33,243,311
G
CAT
catalase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CRHR1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr17:45,784,320...45,835,828
Ensembl chr17:45,784,277...45,835,828
G
DIO3
iodothyronine deiodinase 3
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr14:101,561,495...101,563,452
Ensembl chr14:101,560,139...101,563,452
G
DNMT1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
G
DNMT3B
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
G
DRD2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
EHMT2
euchromatic histone lysine methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 6:31,879,759...31,897,698
Ensembl chr 6:31,879,759...31,897,698
G
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
treatment sexual_dimorphism
ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 , RGD:405866345
NCBI chr15:26,543,552...26,773,763
Ensembl chr15:26,543,552...26,939,539
G
GABRG2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr 5:162,067,465...162,155,539
Ensembl chr 5:162,000,057...162,162,977
G
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 , RGD:13432044
NCBI chr12:13,537,337...13,982,134
Ensembl chr12:13,437,942...13,982,002
G
HDAC2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
G
HDAC4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 2:239,048,168...239,401,649
Ensembl chr 2:239,048,168...239,401,654
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
G
IGF1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
MAT2A
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281
G
MECP2
methyl-CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893 PMID:23763370
RGD:11344152 , RGD:13432044
NCBI chr X:154,021,573...154,097,717
Ensembl chr X:154,021,573...154,137,103
G
MIR326
microRNA 326
ISO
miRNA:increases expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr11:75,335,092...75,335,186
Ensembl chr11:75,335,092...75,335,186
G
MIR7-3
microRNA 7-3
ISO
miRNA:increased expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr19:4,770,670...4,770,779
Ensembl chr19:4,770,670...4,770,779
G
MTR
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278
G
NOS1
nitric oxide synthase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
G
NR3C1
nuclear receptor subfamily 3 group C member 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat) associated with adrenalectomy, chronic stress, female; mRNA:increased expression:prefrontal cortex (rat)
RGD
PMID:29251811 PMID:30367959
RGD:401965484 , RGD:401966864
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NR3C2
nuclear receptor subfamily 3 group C member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
G
OPRK1
opioid receptor kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr 8:53,225,724...53,251,637
Ensembl chr 8:53,225,724...53,251,637
G
OPRL1
opioid related nociceptin receptor 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chr20:64,080,082...64,100,643
Ensembl chr20:64,080,082...64,100,643
G
PDYN
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr20:1,978,756...1,994,285
Ensembl chr20:1,978,757...1,994,285
G
PER2
period circadian regulator 2
treatment
IDA
RGD
PMID:31329297
RGD:405878078
NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102
G
PNOC
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr 8:28,316,988...28,343,351
Ensembl chr 8:28,316,986...28,343,355
G
POMC
proopiomelanocortin
treatment
IDA
RGD
PMID:31329297
RGD:405878078
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
PRL
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
G
PTEN
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
RASGRF1
Ras protein specific guanine nucleotide releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr15:78,959,906...79,090,780
Ensembl chr15:78,959,906...79,090,780
G
RPS6KA1
ribosomal protein S6 kinase A1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 1:26,529,761...26,575,025
Ensembl chr 1:26,529,761...26,575,030
G
SETD7
SET domain containing 7, histone lysine methyltransferase
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 4:139,492,974...139,556,219
Ensembl chr 4:139,495,941...139,606,699
G
SLC25A12
solute carrier family 25 member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 2:171,783,405...171,894,244
Ensembl chr 2:171,783,405...171,999,859
G
SLC6A4
solute carrier family 6 member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
G
TLR4
toll like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
UBE3A
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr15:25,333,728...25,439,056
Ensembl chr15:25,333,728...25,439,051
G
RHOA
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
ISO
RGD
PMID:8229066
RGD:405100718
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
mRNA, protein:increased expression:medial thalamic group, inferior colliculus, neuron
RGD
PMID:18481165
RGD:2300278
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
TKT
transketolase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:3762968
NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all